Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway–PPAR Gamma, Energy Metabolism and Circadian Rhythms

Abbott, R. D., Ross, G. W., White, L. R., Tanner, C. M., Masaki, K. H., Nelson, J. S., et al. (2005). Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology, 65(9), 1442–1446. https://doi.org/10.1212/01.wnl.0000183056.89590.0d.PubMedCrossRef

Abe, M., Herzog, E. D., Yamazaki, S., Straume, M., Tei, H., Sakaki, Y., et al. (2002). Circadian rhythms in isolated brain regions. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 22(1), 350–356.CrossRef

Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997). β-catenin is a target for the ubiquitin–proteasome pathway. The EMBO Journal, 16(13), 3797–3804. https://doi.org/10.1093/emboj/16.13.3797.PubMedPubMedCentralCrossRef

Ahmadian, M., Suh, J. M., Hah, N., Liddle, C., Atkins, A. R., Downes, M., et al. (2013). PPARγ signaling and metabolism: The good, the bad and the future. Nature Medicine, 19(5), 557–566. https://doi.org/10.1038/nm.3159.PubMedCrossRef

Alders, J., Smits, M., Kremer, B., & Naarding, P. (2009). The role of melatonin in sleep disturbances in end-stage Huntington’s disease. The Journal of Neuropsychiatry and Clinical Neurosciences, 21(2), 226–227. https://doi.org/10.1176/jnp.2009.21.2.226.PubMedCrossRef

Al-Harthi, L. (2012). Wnt/β-catenin and its diverse physiological cell signaling pathways in neurodegenerative and neuropsychiatric disorders. Journal of Neuroimmune Pharmacology, 7(4), 725–730. https://doi.org/10.1007/s11481-012-9412-x.PubMedPubMedCentralCrossRef

Ali, T., & Kim, M. O. (2015). Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus. Journal of Pineal Research, 59(1), 47–59. https://doi.org/10.1111/jpi.12238.PubMedCrossRef

Aliev, G., Priyadarshini, M., Reddy, V. P., Grieg, N. H., Kaminsky, Y., Cacabelos, R., et al. (2014). Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease. Current Medicinal Chemistry, 21(19), 2208–2217.PubMedCrossRef

Almeida, M., Ambrogini, E., Han, L., Manolagas, S. C., & Jilka, R. L. (2009). Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-gamma expression, and diminished pro-osteogenic Wnt signaling in the skeleton. The Journal of biological chemistry, 284(40), 27438–27448. https://doi.org/10.1074/jbc.m109.023572.PubMedPubMedCentralCrossRef

Alvarez, A. R., Godoy, J. A., Mullendorff, K., Olivares, G. H., Bronfman, M., & Inestrosa, N. C. (2004). Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons. Experimental Cell Research, 297(1), 186–196. https://doi.org/10.1016/j.yexcr.2004.02.028.PubMedCrossRef

Ambacher, K. K., Pitzul, K. B., Karajgikar, M., Hamilton, A., Ferguson, S. S., & Cregan, S. P. (2012). The JNK- and AKT/GSK3β- signaling pathways converge to regulate puma induction and neuronal apoptosis induced by trophic factor deprivation. PLoS ONE, 7(10), e46885. https://doi.org/10.1371/journal.pone.0046885.PubMedPubMedCentralCrossRef

Anastasiou, D., Poulogiannis, G., Asara, J. M., Boxer, M. B., Jiang, J., Shen, M., et al. (2011). Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science (New York, N.Y.), 334(6060), 1278–1283. https://doi.org/10.1126/science.1211485.CrossRef

Anea, C. B., Zhang, M., Stepp, D. W., Simkins, G. B., Reed, G., Fulton, D. J., et al. (2009). Vascular disease in mice with a dysfunctional circadian clock. Circulation, 119(11), 1510–1517. https://doi.org/10.1161/circulationaha.108.827477.PubMedPubMedCentralCrossRef

Angers, S., & Moon, R. T. (2009). Proximal events in Wnt signal transduction. Nature Reviews Molecular Cell Biology. https://doi.org/10.1038/nrm2717.PubMedCrossRef

Aziz, N. A., Anguelova, G. V., Marinus, J., Lammers, G. J., & Roos, R. A. C. (2010). Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington’s disease. Parkinsonism & Related Disorders, 16(5), 345–350. https://doi.org/10.1016/j.parkreldis.2010.02.009.CrossRef

Aziz, N. A., Pijl, H., Frölich, M., Schröder-van der Elst, J. P., van der Bent, C., Roelfsema, F., et al. (2009). Delayed onset of the diurnal melatonin rise in patients with Huntington’s disease. Journal of Neurology, 256(12), 1961–1965. https://doi.org/10.1007/s00415-009-5196-1.PubMedPubMedCentralCrossRef

Barros, L. F. (2013). Metabolic signaling by lactate in the brain. Trends in Neurosciences, 36(7), 396–404. https://doi.org/10.1016/j.tins.2013.04.002.PubMedCrossRef

Barthel, A., Schmoll, D., & Unterman, T. G. (2005). FoxO proteins in insulin action and metabolism. Trends in endocrinology and metabolism: TEM, 16(4), 183–189. https://doi.org/10.1016/j.tem.2005.03.010.PubMedCrossRef

Bass, J., & Takahashi, J. S. (2010). Circadian integration of metabolism and energetics. Science (New York, N.Y.), 330(6009), 1349–1354. https://doi.org/10.1126/science.1195027.CrossRef

Bauernfeind, A. L., Barks, S. K., Duka, T., Grossman, L. I., Hof, P. R., & Sherwood, C. C. (2014). Aerobic glycolysis in the primate brain: Reconsidering the implications for growth and maintenance. Brain Structure & Function, 219(4), 1149–1167. https://doi.org/10.1007/s00429-013-0662-z.CrossRef

Beaver, L. M., Klichko, V. I., Chow, E. S., Kotwica-Rolinska, J., Williamson, M., Orr, W. C., et al. (2012). Circadian regulation of glutathione levels and biosynthesis in Drosophila melanogaster. PLoS ONE, 7(11), e50454. https://doi.org/10.1371/journal.pone.0050454.PubMedPubMedCentralCrossRef

Bélanger, M., Allaman, I., & Magistretti, P. J. (2011). Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metabolism, 14(6), 724–738. https://doi.org/10.1016/j.cmet.2011.08.016.PubMedCrossRef

Benilova, I., Karran, E., & De Strooper, B. (2012). The toxic Aβ oligomer and Alzheimer’s disease: an emperor in need of clothes. Nature Neuroscience, 15(3), 349–357. https://doi.org/10.1038/nn.3028.PubMedCrossRef

Benzinger, T. L. S., Blazey, T., Jack, C. R., Koeppe, R. A., Su, Y., Xiong, C., et al. (2013). Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease. Proceedings of the National Academy of Sciences of the United States of America, 110(47), E4502–E4509. https://doi.org/10.1073/pnas.1317918110.PubMedPubMedCentralCrossRef

Bero, A. W., Yan, P., Roh, J. H., Cirrito, J. R., Stewart, F. R., Raichle, M. E., et al. (2011). Neuronal activity regulates the regional vulnerability to amyloid-β deposition. Nature Neuroscience, 14(6), 750–756. https://doi.org/10.1038/nn.2801.PubMedPubMedCentralCrossRef

Berwick, D. C., & Harvey, K. (2011). LRRK2 signaling pathways: The key to unlocking neurodegeneration? Trends in Cell Biology, 21(5), 257–265. https://doi.org/10.1016/j.tcb.2011.01.001.PubMedCrossRef

Berwick, D. C., & Harvey, K. (2012). The importance of Wnt signalling for neurodegeneration in Parkinson’s disease. Biochemical Society Transactions, 40(5), 1123–1128. https://doi.org/10.1042/bst20120122.PubMedCrossRef

Besson, M. T., Alegría, K., Garrido-Gerter, P., Barros, L. F., & Liévens, J.-C. (2015). Enhanced neuronal glucose transporter expression reveals metabolic choice in a HD Drosophila model. PLoS ONE, 10(3), e0118765. https://doi.org/10.1371/journal.pone.0118765.PubMedPubMedCentralCrossRef

Blackhall, L. J. (2012). Amyotrophic lateral sclerosis and palliative care: Where we are, and the road ahead. Muscle and Nerve, 45(3), 311–318. https://doi.org/10.1002/mus.22305.PubMedCrossRef

Blesa, J., Trigo-Damas, I., Quiroga-Varela, A., & Jackson-Lewis, V. R. (2015). Oxidative stress and Parkinson’s disease. Frontiers in Neuroanatomy, 9, 91. https://doi.org/10.3389/fnana.2015.00091.PubMedPubMedCentralCrossRef

Bolaños, J. P., Almeida, A., & Moncada, S. (2010). Glycolysis: A bioenergetic or a survival pathway? Trends in Biochemical Sciences, 35(3), 145–149. https://doi.org/10.1016/j.tibs.2009.10.006.PubMedCrossRef

Bonuccelli, U., Del Dotto, P., Lucetti, C., Petrozzi, L., Bernardini, S., Gambaccini, G., et al. (2000). Diurnal motor variations to repeated doses of levodopa in Parkinson’s disease. Clinical Neuropharmacology, 23(1), 28–33.PubMedCrossRef

Boonen, R. A. C. M., van Tijn, P., & Zivkovic, D. (2009). Wnt signaling in Alzheimer’s disease: Up or down, that is the question. Ageing Research Reviews, 8(2), 71–82. https://doi.org/10.1016/j.arr.2008.11.003.PubMedCrossRef

Borghammer, P. (2012). Perfusion and metabolism imaging studies in Parkinson’s disease. Danish Medical Journal, 59(6), B4466.PubMed

Borghammer, P., Chakravarty, M., Jonsdottir, K. Y., Sato, N., Matsuda, H., Ito, K., et al. (2010). Cortical hypometabolism and hypoperfusion in Parkinson’s disease is extensive: Probably even at early disease stages. Brain Structure & Function, 214(4), 303–317. https://doi.org/10.1007/s00429-010-0246-0.CrossRef

Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004). Stages in the development of Parkinson’s disease-related pathology. Cell and Tissue Research, 318(1), 121–134. https://doi.org/10.1007/s00441-004-0956-9.PubMedCrossRef

Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996). Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology, 137(1), 354–366. https://doi.org/10.1210/endo.137.1.8536636.PubMedCrossRef

Bratic, A., & Larsson, N.-G. (2013). The role of mitochondria in aging. The Journal of Clinical Investigation, 123(3), 951–957. https://doi.org/10.1172/jci64125.PubMedPubMedCentralCrossRef

Breen, D. P., Vuono, R., Nawarathna, U., Fisher, K., Shneerson, J. M., Reddy, A. B., et al. (2014). Sleep and circadian rhythm regulation in early Parkinson disease. JAMA neurology, 71(5), 589–595. https://doi.org/10.1001/jamaneurol.2014.65.PubMedPubMedCentralCrossRef

Bright, J. J., Kanakasabai, S., Chearwae, W., & Chakraborty, S. (2008). PPAR regulation of inflammatory signaling in CNS diseases. PPAR research, 2008, 658520. https://doi.org/10.1155/2008/658520.PubMedPubMedCentralCrossRef

Browne, S. E., Yang, L., DiMauro, J.-P., Fuller, S. W., Licata, S. C., & Beal, M. F. (2006). Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS. Neurobiology of Disease, 22(3), 599–610. https://doi.org/10.1016/j.nbd.2006.01.001.PubMedCrossRef

Bunger, M. K., Wilsbacher, L. D., Moran, S. M., Clendenin, C., Radcliffe, L. A., Hogenesch, J. B., et al. (2000). Mop3 is an essential component of the master circadian pacemaker in mammals. Cell, 103(7), 1009–1017.PubMedPubMedCentralCrossRef

Butterfield, D. A., Abdul, H. M., Opii, W., Newman, S. F., Joshi, G., Ansari, M. A., et al. (2006). Pin1 in Alzheimer’s disease. Journal of Neurochemistry, 98(6), 1697–1706. https://doi.org/10.1111/j.1471-4159.2006.03995.x.PubMedCrossRef

Cai, Y., Liu, S., Sothern, R. B., Xu, S., & Chan, P. (2010). Expression of clock genes Per1 and Bmal1 in total leukocytes in health and Parkinson’s disease. European Journal of Neurology, 17(4), 550–554. https://doi.org/10.1111/j.1468-1331.2009.02848.x.PubMedCrossRef

Calvo, J. R., González-Yanes, C., & Maldonado, M. D. (2013). The role of melatonin in the cells of the innate immunity: A review. Journal of Pineal Research, 55(2), 103–120. https://doi.org/10.1111/jpi.12075.PubMedCrossRef

Cao, Y., Wang, H., Ouyang, Q., & Tu, Y. (2015). The free energy cost of accurate biochemical oscillations. Nature Physics, 11(9), 772–778. https://doi.org/10.1038/nphys3412.PubMedPubMedCentralCrossRef

Cardinali, D. P., Pagano, E. S., Scacchi Bernasconi, P. A., Reynoso, R., & Scacchi, P. (2013). Melatonin and mitochondrial dysfunction in the central nervous system. Hormones and Behavior, 63(2), 322–330. https://doi.org/10.1016/j.yhbeh.2012.02.020.PubMedCrossRef

Carta, A. R., Frau, L., Pisanu, A., Wardas, J., Spiga, S., & Carboni, E. (2011). Rosiglitazone decreases peroxisome proliferator receptor-γ levels in microglia and inhibits TNF-α production: New evidences on neuroprotection in a progressive Parkinson’s disease model. Neuroscience, 194, 250–261. https://doi.org/10.1016/j.neuroscience.2011.07.046.PubMedCrossRef

Castellani, R., Hirai, K., Aliev, G., Drew, K. L., Nunomura, A., Takeda, A., et al. (2002). Role of mitochondrial dysfunction in Alzheimer’s disease. Journal of Neuroscience Research, 70(3), 357–360. https://doi.org/10.1002/jnr.10389.PubMedCrossRef

Cepeda, C., Starling, A. J., Wu, N., Nguyen, O. K., Uzgil, B., Soda, T., et al. (2004). Increased GABAergic function in mouse models of Huntington’s disease: Reversal by BDNF. Journal of Neuroscience Research, 78(6), 855–867. https://doi.org/10.1002/jnr.20344.PubMedCrossRef

Chang, H.-C., & Guarente, L. (2013). SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging. Cell, 153(7), 1448–1460. https://doi.org/10.1016/j.cell.2013.05.027.PubMedPubMedCentralCrossRef

Chaturvedi, R. K., Adhihetty, P., Shukla, S., Hennessy, T., Calingasan, N., Yang, L., et al. (2009). Impaired PGC-1alpha function in muscle in Huntington’s disease. Human Molecular Genetics, 18(16), 3048–3065. https://doi.org/10.1093/hmg/ddp243.PubMedPubMedCentralCrossRef

Chaturvedi, R. K., & Beal, M. F. (2008). Mitochondrial approaches for neuroprotection. Annals of the New York Academy of Sciences, 1147, 395–412. https://doi.org/10.1196/annals.1427.027.PubMedPubMedCentralCrossRef

Chen, T. L. (2004). Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment. Bone, 35(1), 83–95. https://doi.org/10.1016/j.bone.2004.03.019.PubMedCrossRef

Chen, H., & Chan, D. C. (2009). Mitochondrial dynamics—fusion, fission, movement, and mitophagy—in neurodegenerative diseases. Human Molecular Genetics, 18(R2), R169–R176. https://doi.org/10.1093/hmg/ddp326.PubMedPubMedCentralCrossRef

Chen, Y., Guan, Y., Liu, H., Wu, X., Yu, L., Wang, S., et al. (2012a). Activation of the Wnt/β-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice. Biochemical and Biophysical Research Communications, 420(2), 397–403. https://doi.org/10.1016/j.bbrc.2012.03.006.PubMedCrossRef

Chen, Y., Guan, Y., Zhang, Z., Liu, H., Wang, S., Yu, L., et al. (2012b). Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice. Neurological Research, 34(4), 390–399. https://doi.org/10.1179/1743132812y.0000000027.PubMedCrossRef

Chen, Y.-C., Wu, J.-S., Tsai, H.-D., Huang, C.-Y., Chen, J.-J., Sun, G. Y., et al. (2012c). Peroxisome proliferator-activated receptor gamma (PPAR-γ) and neurodegenerative disorders. Molecular Neurobiology, 46(1), 114–124. https://doi.org/10.1007/s12035-012-8259-8.PubMedCrossRef

Chen, L., & Yang, G. (2014). PPARs integrate the mammalian clock and energy metabolism. PPAR research, 2014, 653017. https://doi.org/10.1155/2014/653017.PubMedPubMedCentralCrossRef

Chiang, M.-C., Chen, C.-M., Lee, M.-R., Chen, H.-W., Chen, H.-M., Wu, Y.-S., et al. (2010). Modulation of energy deficiency in Huntington’s disease via activation of the peroxisome proliferator-activated receptor gamma. Human Molecular Genetics, 19(20), 4043–4058. https://doi.org/10.1093/hmg/ddq322.PubMedCrossRef

Chiang, M.-C., Cheng, Y.-C., Nicol, C. J., Lin, K.-H., Yen, C.-H., Chen, S.-J., et al. (2015). Rosiglitazone activation of PPARγ-dependent signaling is neuroprotective in mutant huntingtin expressing cells. Experimental Cell Research, 338(2), 183–193. https://doi.org/10.1016/j.yexcr.2015.09.005.PubMedCrossRef

Chiang, M.-C., Nicol, C. J., Cheng, Y.-C., Lin, K.-H., Yen, C.-H., & Lin, C.-H. (2016). Rosiglitazone activation of PPARγ-dependent pathways is neuroprotective in human neural stem cells against amyloid-beta-induced mitochondrial dysfunction and oxidative stress. Neurobiology of Aging, 40, 181–190. https://doi.org/10.1016/j.neurobiolaging.2016.01.132.PubMedCrossRef

Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., et al. (2008). The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature, 452(7184), 230–233. https://doi.org/10.1038/nature06734.PubMedCrossRef

Chuquet, J., Quilichini, P., Nimchinsky, E. A., & Buzsáki, G. (2010). Predominant enhancement of glucose uptake in astrocytes versus neurons during activation of the somatosensory cortex. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 30(45), 15298–15303. https://doi.org/10.1523/jneurosci.0762-10.2010.CrossRef

Cimini, S., Rizzardini, M., Biella, G., & Cantoni, L. (2014). Hypoxia causes autophagic stress and derangement of metabolic adaptation in a cell model of amyotrophic lateral sclerosis. Journal of Neurochemistry, 129(3), 413–425. https://doi.org/10.1111/jnc.12642.PubMedCrossRef

Ciron, C., Lengacher, S., Dusonchet, J., Aebischer, P., & Schneider, B. L. (2012). Sustained expression of PGC-1α in the rat nigrostriatal system selectively impairs dopaminergic function. Human Molecular Genetics, 21(8), 1861–1876. https://doi.org/10.1093/hmg/ddr618.PubMedPubMedCentralCrossRef

Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., et al. (2005). Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron, 48(6), 913–922. https://doi.org/10.1016/j.neuron.2005.10.028.PubMedCrossRef

Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., et al. (2006). Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature, 441(7097), 1162–1166. https://doi.org/10.1038/nature04779.PubMedCrossRef

Clevers, H., & Nusse, R. (2012). Wnt/β-catenin signaling and disease. Cell, 149(6), 1192–1205. https://doi.org/10.1016/j.cell.2012.05.012.PubMedCrossRef

Combs, C. K., Johnson, D. E., Karlo, J. C., Cannady, S. B., & Landreth, G. E. (2000). Inflammatory mechanisms in Alzheimer’s disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 20(2), 558–567.CrossRef

Coogan, A. N., Schutová, B., Husung, S., Furczyk, K., Baune, B. T., Kropp, P., et al. (2013). The circadian system in Alzheimer’s disease: Disturbances, mechanisms, and opportunities. Biological Psychiatry, 74(5), 333–339. https://doi.org/10.1016/j.biopsych.2012.11.021.PubMedCrossRef

Coppola, G., Marmolino, D., Lu, D., Wang, Q., Cnop, M., Rai, M., et al. (2009). Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreich’s ataxia. Human Molecular Genetics, 18(13), 2452–2461. https://doi.org/10.1093/hmg/ddp183.PubMedPubMedCentralCrossRef

Corona, J. C., & Duchen, M. R. (2015). PPARγ and PGC-1α as therapeutic targets in Parkinson’s. Neurochemical Research, 40(2), 308–316. https://doi.org/10.1007/s11064-014-1377-0.PubMedCrossRef

Crowley, S. J., & Eastman, C. I. (2013). Melatonin in the afternoons of a gradually advancing sleep schedule enhances the circadian rhythm phase advance. Psychopharmacology (Berl), 225(4), 825–837. https://doi.org/10.1007/s00213-012-2869-8.CrossRef

Csernus, V., & Mess, B. (2003). Biorhythms and pineal gland. Neuro Endocrinology Letters, 24(6), 404–411.PubMed

Cuadrado-Tejedor, M., Vilariño, M., Cabodevilla, F., Del Río, J., Frechilla, D., & Pérez-Mediavilla, A. (2011). Enhanced expression of the voltage-dependent anion channel 1 (VDAC1) in Alzheimer’s disease transgenic mice: An insight into the pathogenic effects of amyloid-β. Journal of Alzheimer’s disease: JAD, 23(2), 195–206. https://doi.org/10.3233/jad-2010-100966.PubMedCrossRef

Cui, L., Jeong, H., Borovecki, F., Parkhurst, C. N., Tanese, N., & Krainc, D. (2006). Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell, 127(1), 59–69. https://doi.org/10.1016/j.cell.2006.09.015.PubMedCrossRef

Cuitino, L., Godoy, J. A., Farías, G. G., Couve, A., Bonansco, C., Fuenzalida, M., et al. (2010). Wnt-5a modulates recycling of functional GABAA receptors on hippocampal neurons. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 30(25), 8411–8420. https://doi.org/10.1523/jneurosci.5736-09.2010.CrossRef

Cuturic, M., Abramson, R. K., Vallini, D., Frank, E. M., & Shamsnia, M. (2009). Sleep patterns in patients with Huntington’s disease and their unaffected first-degree relatives: A brief report. Behavioral Sleep Medicine, 7(4), 245–254. https://doi.org/10.1080/15402000903190215.PubMedCrossRef

Czeisler, C. A., Dumont, M., Duffy, J. F., Steinberg, J. D., Richardson, G. S., Brown, E. N., et al. (1992). Association of sleep-wake habits in older people with changes in output of circadian pacemaker. Lancet (London, England), 340(8825), 933–936.CrossRef

d’Abramo, C., Massone, S., Zingg, J.-M., Pizzuti, A., Marambaud, P., Dalla Piccola, B., et al. (2005). Role of peroxisome proliferator-activated receptor gamma in amyloid precursor protein processing and amyloid beta-mediated cell death. The Biochemical Journal, 391(Pt 3), 693–698. https://doi.org/10.1042/bj20050560.PubMedPubMedCentralCrossRef

Damiano, M., Diguet, E., Malgorn, C., D’Aurelio, M., Galvan, L., Petit, F., et al. (2013). A role of mitochondrial complex II defects in genetic models of Huntington’s disease expressing N-terminal fragments of mutant huntingtin. Human Molecular Genetics, 22(19), 3869–3882. https://doi.org/10.1093/hmg/ddt242.PubMedPubMedCentralCrossRef

Damiano, M., Galvan, L., Déglon, N., & Brouillet, E. (2010). Mitochondria in Huntington’s disease. Biochimica et Biophysica Acta, 1802(1), 52–61. https://doi.org/10.1016/j.bbadis.2009.07.012.PubMedCrossRef

Daynes, R. A., & Jones, D. C. (2002). Emerging roles of PPARs in inflammation and immunity. Nature Reviews Immunology, 2(10), 748–759. https://doi.org/10.1038/nri912.PubMedCrossRef

De Cruz, S., Espiritu, J. R. D., Zeidler, M., & Wang, T. S. (2012). Sleep disorders in chronic liver disease. Seminars in Respiratory and Critical Care Medicine, 33(1), 26–35. https://doi.org/10.1055/s-0032-1301732.PubMedCrossRef

de la Monte, S. M., & Wands, J. R. (2006). Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer’s disease. Journal of Alzheimer’s disease: JAD, 9(2), 167–181.PubMedCrossRef

Demetrius, L. A., & Driver, J. (2013). Alzheimer’s as a metabolic disease. Biogerontology, 14(6), 641–649. https://doi.org/10.1007/s10522-013-9479-7.PubMedCrossRef

Demetrius, L. A., Magistretti, P. J., & Pellerin, L. (2014). Alzheimer’s disease: The amyloid hypothesis and the Inverse Warburg effect. Frontiers in Physiology, 5, 522. https://doi.org/10.3389/fphys.2014.00522.PubMedCrossRef

Demetrius, L. A., & Simon, D. K. (2012). An inverse-Warburg effect and the origin of Alzheimer’s disease. Biogerontology, 13(6), 583–594. https://doi.org/10.1007/s10522-012-9403-6.PubMedCrossRef

Devos, D., Kroumova, M., Bordet, R., Vodougnon, H., Guieu, J. D., Libersa, C., et al. (2003). Heart rate variability and Parkinson’s disease severity. Journal of Neural Transmission (Vienna, Austria: 1996), 110(9), 997–1011. https://doi.org/10.1007/s00702-003-0016-8.CrossRef

Dickins, E. M., & Salinas, P. C. (2013). Wnts in action: From synapse formation to synaptic maintenance. Frontiers in Cellular Neuroscience, 7, 162. https://doi.org/10.3389/fncel.2013.00162.PubMedPubMedCentralCrossRef

Dienel, G. A. (2012). Brain lactate metabolism: The discoveries and the controversies. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 32(7), 1107–1138. https://doi.org/10.1038/jcbfm.2011.175.CrossRef

DiNuzzo, M., Maraviglia, B., & Giove, F. (2011). Why does the brain (not) have glycogen? BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology, 33(5), 319–326. https://doi.org/10.1002/bies.201000151.CrossRef

Djouadi, F., Lecarpentier, Y., Hébert, J.-L., Charron, P., Bastin, J., & Coirault, C. (2009). A potential link between peroxisome proliferator-activated receptor signalling and the pathogenesis of arrhythmogenic right ventricular cardiomyopathy. Cardiovascular Research, 84(1), 83–90. https://doi.org/10.1093/cvr/cvp183.PubMedCrossRef

Dong, H., Yuede, C. M., Yoo, H.-S., Martin, M. V., Deal, C., Mace, A. G., et al. (2008). Corticosterone and related receptor expression are associated with increased beta-amyloid plaques in isolated Tg2576 mice. Neuroscience, 155(1), 154–163. https://doi.org/10.1016/j.neuroscience.2008.05.017.PubMedCrossRef

Drew, P. D., Xu, J., & Racke, M. K. (2008). PPAR-gamma: Therapeutic potential for multiple sclerosis. PPAR research, 2008, 627463. https://doi.org/10.1155/2008/627463.PubMedPubMedCentralCrossRef

Dubocovich, M. L. (2007). Melatonin receptors: Role on sleep and circadian rhythm regulation. Sleep Medicine, 8(Suppl 3), 34–42. https://doi.org/10.1016/j.sleep.2007.10.007.PubMedCrossRef

Duffield, G. E., Best, J. D., Meurers, B. H., Bittner, A., Loros, J. J., & Dunlap, J. C. (2002). Circadian programs of transcriptional activation, signaling, and protein turnover revealed by microarray analysis of mammalian cells. Current biology: CB, 12(7), 551–557.PubMedCrossRef

Duffy, J. F., Zeitzer, J. M., Rimmer, D. W., Klerman, E. B., Dijk, D.-J., & Czeisler, C. A. (2002). Peak of circadian melatonin rhythm occurs later within the sleep of older subjects. American journal of physiology. Endocrinology and metabolism, 282(2), E297–E303. https://doi.org/10.1152/ajpendo.00268.2001.PubMedCrossRef

Duggan, S. P., & McCarthy, J. V. (2016). Beyond γ-secretase activity: The multifunctional nature of presenilins in cell signalling pathways. Cellular Signalling, 28(1), 1–11. https://doi.org/10.1016/j.cellsig.2015.10.006.PubMedCrossRef

Dun, Y., Li, G., Yang, Y., Xiong, Z., Feng, M., Wang, M., et al. (2012). Inhibition of the canonical Wnt pathway by Dickkopf-1 contributes to the neurodegeneration in 6-OHDA-lesioned rats. Neuroscience Letters, 525(2), 83–88. https://doi.org/10.1016/j.neulet.2012.07.030.PubMedCrossRef

Duncan, M. J., Smith, J. T., Franklin, K. M., Beckett, T. L., Murphy, M. P., St Clair, D. K., et al. (2012). Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer’s disease. Experimental Neurology, 236(2), 249–258. https://doi.org/10.1016/j.expneurol.2012.05.011.PubMedCrossRef

Dunn, L., Allen, G. F., Mamais, A., Ling, H., Li, A., Duberley, K. E., et al. (2014). Dysregulation of glucose metabolism is an early event in sporadic Parkinson’s disease. Neurobiology of Aging, 35(5), 1111–1115. https://doi.org/10.1016/j.neurobiolaging.2013.11.001.PubMedPubMedCentralCrossRef

Dupont, P., Besson, M.-T., Devaux, J., & Liévens, J.-C. (2012). Reducing canonical Wingless/Wnt signaling pathway confers protection against mutant Huntingtin toxicity in Drosophila. Neurobiology of Disease, 47(2), 237–247. https://doi.org/10.1016/j.nbd.2012.04.007.PubMedCrossRef

Dupuis, L., Pradat, P.-F., Ludolph, A. C., & Loeffler, J.-P. (2011). Energy metabolism in amyotrophic lateral sclerosis. The Lancet Neurology, 10(1), 75–82. https://doi.org/10.1016/s1474-4422(10)70224-6.PubMedCrossRef

Edison, P., Ahmed, I., Fan, Z., Hinz, R., Gelosa, G., Ray Chaudhuri, K., et al. (2013). Microglia, amyloid, and glucose metabolism in Parkinson’s disease with and without dementia. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 38(6), 938–949. https://doi.org/10.1038/npp.2012.255.CrossRef

Ehrnhoefer, D. E., Wong, B. K. Y., & Hayden, M. R. (2011). Convergent pathogenic pathways in Alzheimer’s and Huntington’s diseases: Shared targets for drug development. Nature Reviews Drug Discovery, 10(11), 853–867. https://doi.org/10.1038/nrd3556.PubMedPubMedCentralCrossRef

Elbrecht, A., Chen, Y., Cullinan, C. A., Hayes, N., Leibowitz, M. D., Moller, D. E., et al. (1996). Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochemical and Biophysical Research Communications, 224(2), 431–437.PubMedCrossRef

El-Sahar, A. E., Safar, M. M., Zaki, H. F., Attia, A. S., & Ain-Shoka, A. A. (2015). Neuroprotective effects of pioglitazone against transient cerebral ischemic reperfusion injury in diabetic rats: Modulation of antioxidant, anti-inflammatory, and anti-apoptotic biomarkers. Pharmacological reports: PR, 67(5), 901–906. https://doi.org/10.1016/j.pharep.2015.03.018.PubMedCrossRef

Escribano, L., Simón, A.-M., Gimeno, E., Cuadrado-Tejedor, M., López de Maturana, R., García-Osta, A., et al. (2010). Rosiglitazone rescues memory impairment in Alzheimer’s transgenic mice: Mechanisms involving a reduced amyloid and tau pathology. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 35(7), 1593–1604. https://doi.org/10.1038/npp.2010.32.CrossRef

Esmaeili, M. A., Yadav, S., Gupta, R. K., Waggoner, G. R., Deloach, A., Calingasan, N. Y., et al. (2016). Preferential PPAR-α activation reduces neuroinflammation, and blocks neurodegeneration in vivo. Human Molecular Genetics, 25(2), 317–327. https://doi.org/10.1093/hmg/ddv477.PubMedCrossRef

Essers, M. A. G., de Vries-Smits, L. M. M., Barker, N., Polderman, P. E., Burgering, B. M. T., & Korswagen, H. C. (2005). Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science (New York, N.Y.), 308(5725), 1181–1184. https://doi.org/10.1126/science.1109083.CrossRef

Evans, J. A., & Davidson, A. J. (2013). Health consequences of circadian disruption in humans and animal models. Progress in Molecular Biology and Translational Science, 119, 283–323. https://doi.org/10.1016/b978-0-12-396971-2.00010-5.PubMedCrossRef

Fajas, L., Auboeuf, D., Raspé, E., Schoonjans, K., Lefebvre, A. M., Saladin, R., et al. (1997). The organization, promoter analysis, and expression of the human PPARgamma gene. The Journal of biological Chemistry, 272(30), 18779–18789.PubMedCrossRef

Farajnia, S., Michel, S., Deboer, T., Vander leest, H. T., Houben, T., Rohling, J. H. T., et al. (2012). Evidence for neuronal desynchrony in the aged suprachiasmatic nucleus clock. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 32(17), 5891–5899. https://doi.org/10.1523/jneurosci.0469-12.2012.CrossRef

Farshbaf, M. J., Ghaedi, K., Shirani, M., & Nasr-Esfahani, M. H. (2014). Peroxisome proliferator activated receptor gamma (PPARγ) as a therapeutic target for improvement of cognitive performance in Fragile-X. Medical Hypotheses, 82(3), 291–294. https://doi.org/10.1016/j.mehy.2013.12.012.PubMedCrossRef

Feng, Z., Qin, C., Chang, Y., & Zhang, J. (2006). Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer’s disease. Free Radical Biology and Medicine, 40(1), 101–109. https://doi.org/10.1016/j.freeradbiomed.2005.08.014.PubMedCrossRef

Fernández de Mattos, S., Essafi, A., Soeiro, I., Pietersen, A. M., Birkenkamp, K. U., Edwards, C. S., et al. (2004). FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism. Molecular and Cellular Biology, 24(22), 10058–10071. https://doi.org/10.1128/mcb.24.22.10058-10071.2004.PubMedPubMedCentralCrossRef

Finkbeiner, S. (2011). Huntington’s disease. Cold Spring Harbor Perspectives in Biology, 3(6), a007476. https://doi.org/10.1101/cshperspect.a007476.PubMedPubMedCentralCrossRef

Fontaine, C., Dubois, G., Duguay, Y., Helledie, T., Vu-Dac, N., Gervois, P., et al. (2003). The orphan nuclear receptor Rev-Erbalpha is a peroxisome proliferator-activated receptor (PPAR) gamma target gene and promotes PPARgamma-induced adipocyte differentiation. The Journal of biological chemistry, 278(39), 37672–37680. https://doi.org/10.1074/jbc.m304664200.PubMedCrossRef

Franco-Iborra, S., Vila, M., & Perier, C. (2016). The Parkinson disease mitochondrial hypothesis: Where are we at? The Neuroscientist: A Review Journal Bringing Neurobiology, Neurology and Psychiatry, 22(3), 266–277. https://doi.org/10.1177/1073858415574600.CrossRef

Fuenzalida, K., Quintanilla, R., Ramos, P., Piderit, D., Fuentealba, R. A., Martinez, G., et al. (2007). Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis. The Journal of biological chemistry, 282(51), 37006–37015. https://doi.org/10.1074/jbc.m700447200.PubMedCrossRef

Galano, A., Tan, D. X., & Reiter, R. J. (2013). On the free radical scavenging activities of melatonin’s metabolites, AFMK and AMK. Journal of Pineal Research, 54(3), 245–257. https://doi.org/10.1111/jpi.12010.PubMedCrossRef

Galea, E., Heneka, M. T., Dello Russo, C., & Feinstein, D. L. (2003). Intrinsic regulation of brain inflammatory responses. Cellular and Molecular Neurobiology, 23(4–5), 625–635.PubMedCrossRef

Gao, J., Huang, X., Park, Y., Hollenbeck, A., Blair, A., Schatzkin, A., et al. (2011). Daytime napping, nighttime sleeping, and Parkinson disease. American Journal of Epidemiology, 173(9), 1032–1038. https://doi.org/10.1093/aje/kwq478.PubMedPubMedCentralCrossRef

García-Bueno, B., Caso, J. R., Pérez-Nievas, B. G., Lorenzo, P., & Leza, J. C. (2007). Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 32(6), 1251–1260. https://doi.org/10.1038/sj.npp.1301252.CrossRef

García-Bueno, B., Madrigal, J. L. M., Lizasoain, I., Moro, M. A., Lorenzo, P., & Leza, J. C. (2005). The anti-inflammatory prostaglandin 15d-PGJ2 decreases oxidative/nitrosative mediators in brain after acute stress in rats. Psychopharmacology (Berl), 180(3), 513–522. https://doi.org/10.1007/s00213-005-2195-5.CrossRef

Garcia-Gras, E., Lombardi, R., Giocondo, M. J., Willerson, J. T., Schneider, M. D., Khoury, D. S., et al. (2006). Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. The Journal of Clinical Investigation, 116(7), 2012–2021. https://doi.org/10.1172/jci27751.PubMedPubMedCentralCrossRef

García-Martínez, R., & Córdoba, J. (2011). Acute-on-chronic liver failure: the brain. Current Opinion in Critical Care, 17(2), 177–183. https://doi.org/10.1097/mcc.0b013e328344b37e.PubMedCrossRef

García-Mesa, Y., Giménez-Llort, L., López, L. C., Venegas, C., Cristòfol, R., Escames, G., et al. (2012). Melatonin plus physical exercise are highly neuroprotective in the 3xTg-AD mouse. Neurobiology of Aging, 33(6), 1124.e13-29. https://doi.org/10.1016/j.neurobiolaging.2011.11.016.PubMedCrossRef

Gargiulo Monachelli, G., Meyer, M., Rodríguez, G. E., Garay, L. I., Sica, R. E. P., De Nicola, A. F., et al. (2011). Endogenous progesterone is associated to amyotrophic lateral sclerosis prognostic factors. Acta Neurologica Scandinavica, 123(1), 60–67. https://doi.org/10.1111/j.1600-0404.2010.01385.x.PubMedCrossRef

Gargiulo-Monachelli, G. M., Sivori, M., Meyer, M., Sica, R. E. P., De Nicola, A. F., & Gonzalez-Deniselle, M. C. (2014). Circulating gonadal and adrenal steroids in amyotrophic lateral sclerosis: Possible markers of susceptibility and outcome. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme, 46(6), 433–439. https://doi.org/10.1055/s-0034-1371891.PubMedCrossRef

Gekakis, N., Staknis, D., Nguyen, H. B., Davis, F. C., Wilsbacher, L. D., King, D. P., et al. (1998). Role of the CLOCK protein in the mammalian circadian mechanism. Science (New York, N.Y.), 280(5369), 1564–1569.CrossRef

Ghosh, P. S., Hupertz, V., & Ghosh, D. (2012). Neurological complications following pediatric liver transplant. Journal of Pediatric Gastroenterology and Nutrition, 54(4), 540–546. https://doi.org/10.1097/mpg.0b013e3182407de3.PubMedCrossRef

Ghosh, S., Patel, N., Rahn, D., McAllister, J., Sadeghi, S., Horwitz, G., et al. (2007). The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells. Molecular Pharmacology, 71(6), 1695–1702. https://doi.org/10.1124/mol.106.033845.PubMedCrossRef

Gibson, E. M., Wang, C., Tjho, S., Khattar, N., & Kriegsfeld, L. J. (2010). Experimental “jet lag” inhibits adult neurogenesis and produces long-term cognitive deficits in female hamsters. PLoS ONE, 5(12), e15267. https://doi.org/10.1371/journal.pone.0015267.PubMedPubMedCentralCrossRef

Giese, K. P. (2009). GSK-3: A key player in neurodegeneration and memory. IUBMB Life, 61(5), 516–521. https://doi.org/10.1002/iub.187.PubMedCrossRef

Gines, S., Ivanova, E., Seong, I.-S., Saura, C. A., & MacDonald, M. E. (2003). Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington’s disease knock-in striatal cells. The Journal of biological chemistry, 278(50), 50514–50522. https://doi.org/10.1074/jbc.m309348200.PubMedCrossRef

Godin, J. D., Poizat, G., Hickey, M. A., Maschat, F., & Humbert, S. (2010). Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington’s disease. The EMBO journal, 29(14), 2433–2445. https://doi.org/10.1038/emboj.2010.117.PubMedPubMedCentralCrossRef

Goldbeter, A. (1973). Patterns of spatiotemporal organization in an allosteric enzyme model. Proceedings of the National Academy of Sciences of the United States of America, 70(11), 3255–3259.PubMedPubMedCentralCrossRef

Goldbeter, A. (2002). Computational approaches to cellular rhythms. Nature, 420(6912), 238–245. https://doi.org/10.1038/nature01259.PubMedCrossRef

Goodwin, B. C. (1965). Oscillatory behavior in enzymatic control processes. Advances in Enzyme Regulation, 3, 425–438.PubMedCrossRef

Grandemange, S., Herzig, S., & Martinou, J.-C. (2009). Mitochondrial dynamics and cancer. Seminars in Cancer Biology, 19(1), 50–56. https://doi.org/10.1016/j.semcancer.2008.12.001.PubMedCrossRef

Gravotta, L., Gavrila, A. M., Hood, S., & Amir, S. (2011). Global depletion of dopamine using intracerebroventricular 6-hydroxydopamine injection disrupts normal circadian wheel-running patterns and PERIOD2 expression in the rat forebrain. Journal of molecular neuroscience: MN, 45(2), 162–171. https://doi.org/10.1007/s12031-011-9520-8.PubMedCrossRef

Green, K. N., Billings, L. M., Roozendaal, B., McGaugh, J. L., & LaFerla, F. M. (2006). Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer’s disease. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 26(35), 9047–9056. https://doi.org/10.1523/jneurosci.2797-06.2006.CrossRef

Green, C. B., Douris, N., Kojima, S., Strayer, C. A., Fogerty, J., Lourim, D., et al. (2007). Loss of Nocturnin, a circadian deadenylase, confers resistance to hepatic steatosis and diet-induced obesity. Proceedings of the National Academy of Sciences of the United States of America, 104(23), 9888–9893. https://doi.org/10.1073/pnas.0702448104.PubMedPubMedCentralCrossRef

Grinberg, L. T., Rueb, U., di Lorenzo Alho, A. T., & Heinsen, H. (2010). Brainstem pathology and non-motor symptoms in PD. Journal of the Neurological Sciences, 289(1–2), 81–88. https://doi.org/10.1016/j.jns.2009.08.021.PubMedCrossRef

Guo, B., Chatterjee, S., Li, L., Kim, J. M., Lee, J., Yechoor, V. K., et al. (2012). The clock gene, brain and muscle Arnt-like 1, regulates adipogenesis via Wnt signaling pathway. FASEB Journal: official Publication of the Federation of American Societies for Experimental Biology, 26(8), 3453–3463. https://doi.org/10.1096/fj.12-205781.CrossRef

Guven, C., Taskin, E., & Akcakaya, H. (2016). Melatonin prevents mitochondrial damage induced by doxorubicin in mouse fibroblasts through AMPK-PPAR gamma-dependent mechanisms. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 22, 438–446.CrossRef

Häbig, K., Walter, M., Poths, S., Riess, O., & Bonin, M. (2008). RNA interference of LRRK2-microarray expression analysis of a Parkinson’s disease key player. Neurogenetics, 9(2), 83–94. https://doi.org/10.1007/s10048-007-0114-0.PubMedCrossRef

Hahn, E. A., Wang, H.-X., Andel, R., & Fratiglioni, L. (2014). A change in sleep pattern may predict Alzheimer disease. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 22(11), 1262–1271. https://doi.org/10.1016/j.jagp.2013.04.015.CrossRef

Halim, N. D., Mcfate, T., Mohyeldin, A., Okagaki, P., Korotchkina, L. G., Patel, M. S., et al. (2010). Phosphorylation status of pyruvate dehydrogenase distinguishes metabolic phenotypes of cultured rat brain astrocytes and neurons. Glia, 58(10), 1168–1176. https://doi.org/10.1002/glia.20996.PubMedPubMedCentralCrossRef

Haramizu, S., Ota, N., Hase, T., & Murase, T. (2011). Aging-associated changes in physical performance and energy metabolism in the senescence-accelerated mouse. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 66(6), 646–655. https://doi.org/10.1093/gerona/glr037.PubMedCrossRef

Hardin, P. E., Hall, J. C., & Rosbash, M. (1990). Feedback of the Drosophila period gene product on circadian cycling of its messenger RNA levels. Nature, 343(6258), 536–540. https://doi.org/10.1038/343536a0.PubMedCrossRef

Harris, R. A., Tindale, L., & Cumming, R. C. (2014). Age-dependent metabolic dysregulation in cancer and Alzheimer’s disease. Biogerontology, 15(6), 559–577. https://doi.org/10.1007/s10522-014-9534-z.PubMedCrossRef

Harrison-Uy, S. J., & Pleasure, S. J. (2012). Wnt signaling and forebrain development. Cold Spring Harbor Perspectives in Biology, 4(7), a008094. https://doi.org/10.1101/cshperspect.a008094.PubMedPubMedCentralCrossRef

Hatfield, C. F., Herbert, J., van Someren, E. J. W., Hodges, J. R., & Hastings, M. H. (2004). Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer’s dementia. Brain: A Journal of Neurology, 127, 1061–1074. https://doi.org/10.1093/brain/awh129.CrossRef

He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., et al. (1998). Identification of c-MYC as a target of the APC pathway. Science (New York, N.Y.), 281(5382), 1509–1512.CrossRef

Heneka, M. T., Sastre, M., Dumitrescu-Ozimek, L., Dewachter, I., Walter, J., Klockgether, T., et al. (2005). Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice. Journal of Neuroinflammation, 2, 22. https://doi.org/10.1186/1742-2094-2-22.PubMedPubMedCentralCrossRef

Heras-Sandoval, D., Pérez-Rojas, J. M., Hernández-Damián, J., & Pedraza-Chaverri, J. (2014). The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cellular Signalling, 26(12), 2694–2701. https://doi.org/10.1016/j.cellsig.2014.08.019.PubMedCrossRef

Herrero-Mendez, A., Almeida, A., Fernández, E., Maestre, C., Moncada, S., & Bolaños, J. P. (2009). The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nature Cell Biology, 11(6), 747–752. https://doi.org/10.1038/ncb1881.PubMedCrossRef

Herskovits, A. Z., & Guarente, L. (2013). Sirtuin deacetylases in neurodegenerative diseases of aging. Cell Research, 23(6), 746–758. https://doi.org/10.1038/cr.2013.70.PubMedPubMedCentralCrossRef

Hirsch, E. C., Vyas, S., & Hunot, S. (2012). Neuroinflammation in Parkinson’s disease. Parkinsonism & Related Disorders, 18(Suppl 1), S210–S212. https://doi.org/10.1016/s1353-8020(11)70065-7.CrossRef

Hoepken, H.-H., Gispert, S., Morales, B., Wingerter, O., Del Turco, D., Mülsch, A., et al. (2007). Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6. Neurobiology of Disease, 25(2), 401–411. https://doi.org/10.1016/j.nbd.2006.10.007.PubMedCrossRef

Hofman, M. A. (2000). The human circadian clock and aging. Chronobiology International, 17(3), 245–259.PubMedCrossRef

Hogenesch, J. B., Gu, Y. Z., Jain, S., & Bradfield, C. A. (1998). The basic-helix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors. Proceedings of the National Academy of Sciences of the United States of America, 95(10), 5474–5479.PubMedPubMedCentralCrossRef

Hood, S., Cassidy, P., Cossette, M.-P., Weigl, Y., Verwey, M., Robinson, B., et al. (2010). Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 30(42), 14046–14058. https://doi.org/10.1523/jneurosci.2128-10.2010.CrossRef

Hoogeboom, D., Essers, M. A. G., Polderman, P. E., Voets, E., Smits, L. M. M., & Burgering, B. M. T. (2008). Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity. The Journal of biological chemistry, 283(14), 9224–9230. https://doi.org/10.1074/jbc.m706638200.PubMedCrossRef

Hooper, C., Killick, R., & Lovestone, S. (2008). The GSK3 hypothesis of Alzheimer’s disease. Journal of Neurochemistry, 104(6), 1433–1439. https://doi.org/10.1111/j.1471-4159.2007.05194.x.PubMedPubMedCentralCrossRef

Hoppe, J. B., Frozza, R. L., Horn, A. P., Comiran, R. A., Bernardi, A., Campos, M. M., et al. (2010). Amyloid-beta neurotoxicity in organotypic culture is attenuated by melatonin: Involvement of GSK-3beta, tau and neuroinflammation. Journal of Pineal Research, 48(3), 230–238. https://doi.org/10.1111/j.1600-079x.2010.00747.x.PubMedCrossRef

Huang, Y., Potter, R., Sigurdson, W., Santacruz, A., Shih, S., Ju, Y.-E., et al. (2012). Effects of age and amyloid deposition on Aβ dynamics in the human central nervous system. Archives of Neurology, 69(1), 51–58. https://doi.org/10.1001/archneurol.2011.235.PubMedCrossRef

Hult, S., Schultz, K., Soylu, R., & Petersén, A. (2010). Hypothalamic and neuroendocrine changes in Huntington’s disease. Current Drug Targets, 11(10), 1237–1249.PubMedCrossRef

Humbert, S., Bryson, E. A., Cordelières, F. P., Connors, N. C., Datta, S. R., Finkbeiner, S., et al. (2002). The IGF-1/Akt pathway is neuroprotective in Huntington’s disease and involves Huntingtin phosphorylation by Akt. Developmental Cell, 2(6), 831–837.PubMedCrossRef

Hunt, T. K., Aslam, R. S., Beckert, S., Wagner, S., Ghani, Q. P., Hussain, M. Z., et al. (2007). Aerobically derived lactate stimulates revascularization and tissue repair via redox mechanisms. Antioxidants & Redox Signaling, 9(8), 1115–1124. https://doi.org/10.1089/ars.2007.1674.CrossRef

Hur, E.-M., & Zhou, F.-Q. (2010). GSK3 signalling in neural development. Nature Reviews Neuroscience, 11(8), 539–551. https://doi.org/10.1038/nrn2870.PubMedPubMedCentralCrossRef

Ille, F., & Sommer, L. (2005). Wnt signaling: Multiple functions in neural development. Cellular and molecular life sciences: CMLS, 62(10), 1100–1108. https://doi.org/10.1007/s00018-005-4552-2.PubMedCrossRef

Imbesi, M., Yildiz, S., Dirim Arslan, A., Sharma, R., Manev, H., & Uz, T. (2009). Dopamine receptor-mediated regulation of neuronal “clock” gene expression. Neuroscience, 158(2), 537–544. https://doi.org/10.1016/j.neuroscience.2008.10.044.PubMedCrossRef

Inestrosa, N. C., & Arenas, E. (2010). Emerging roles of Wnts in the adult nervous system. Nature Reviews Neuroscience, 11(2), 77–86. https://doi.org/10.1038/nrn2755.PubMedCrossRef

Inestrosa, N. C., Montecinos-Oliva, C., & Fuenzalida, M. (2012). Wnt signaling: role in Alzheimer disease and schizophrenia. Journal of Neuroimmune Pharmacology: The Official Journal of the Society on NeuroImmune Pharmacology, 7(4), 788–807. https://doi.org/10.1007/s11481-012-9417-5.CrossRef

Inestrosa, N. C., & Varela-Nallar, L. (2014). Wnt signaling in the nervous system and in Alzheimer’s disease. Journal of Molecular Cell Biology, 6(1), 64–74. https://doi.org/10.1093/jmcb/mjt051.PubMedCrossRef

Islam, M. T. (2017). Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders. Neurological Research, 39(1), 73–82. https://doi.org/10.1080/01616412.2016.1251711.PubMedCrossRef

Jakoby, P., Schmidt, E., Ruminot, I., Gutiérrez, R., Barros, L. F., & Deitmer, J. W. (2014). Higher transport and metabolism of glucose in astrocytes compared with neurons: A multiphoton study of hippocampal and cerebellar tissue slices. Cerebral Cortex (New York, N.Y.: 1991), 24(1), 222–231. https://doi.org/10.1093/cercor/bhs309.CrossRef

Janich, P., Pascual, G., Merlos-Suárez, A., Batlle, E., Ripperger, J., Albrecht, U., et al. (2011). The circadian molecular clock creates epidermal stem cell heterogeneity. Nature, 480(7376), 209–214. https://doi.org/10.1038/nature10649.PubMedCrossRef

Johri, A., & Beal, M. F. (2012). Mitochondrial dysfunction in neurodegenerative diseases. The Journal of Pharmacology and Experimental Therapeutics, 342(3), 619–630. https://doi.org/10.1124/jpet.112.192138.PubMedPubMedCentralCrossRef

Johri, A., Starkov, A. A., Chandra, A., Hennessey, T., Sharma, A., Orobello, S., et al. (2011). Truncated peroxisome proliferator-activated receptor-γ coactivator 1α splice variant is severely altered in Huntington’s disease. Neuro-Degenerative Diseases, 8(6), 496–503. https://doi.org/10.1159/000327910.PubMedPubMedCentralCrossRef

Joshi, P. R., Wu, N.-P., André, V. M., Cummings, D. M., Cepeda, C., Joyce, J. A., et al. (2009). Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 29(8), 2414–2427. https://doi.org/10.1523/jneurosci.5687-08.2009.CrossRef

Ju, Y.-E. S., Lucey, B. P., & Holtzman, D. M. (2014). Sleep and Alzheimer disease pathology—A bidirectional relationship. Nature Reviews. Neurology, 10(2), 115–119. https://doi.org/10.1038/nrneurol.2013.269.PubMedCrossRef

Jucker, M., & Walker, L. C. (2011). Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Annals of Neurology, 70(4), 532–540. https://doi.org/10.1002/ana.22615.PubMedPubMedCentralCrossRef

Kalliolia, E., Silajdžić, E., Nambron, R., Hill, N. R., Doshi, A., Frost, C., et al. (2014). Plasma melatonin is reduced in Huntington’s disease. Movement Disorders: Official Journal of the Movement Disorder Society, 29(12), 1511–1515. https://doi.org/10.1002/mds.26003.CrossRef

Kalman, B. A., & Grahn, R. E. (2004). Measuring salivary cortisol in the behavioral neuroscience laboratory. Journal of Undergraduate Neuroscience Education: JUNE: A Publication of FUN, Faculty for Undergraduate Neuroscience, 2(2), A41–A49.

Kalonia, H., Kumar, P., & Kumar, A. (2011). Attenuation of proinflammatory cytokines and apoptotic process by verapamil and diltiazem against quinolinic acid induced Huntington like alterations in rats. Brain Research, 1372, 115–126. https://doi.org/10.1016/j.brainres.2010.11.060.PubMedCrossRef

Kang, J.-E., Lim, M. M., Bateman, R. J., Lee, J. J., Smyth, L. P., Cirrito, J. R., et al. (2009). Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science (New York, N.Y.), 326(5955), 1005–1007. https://doi.org/10.1126/science.1180962.CrossRef

Kapadia, R., Yi, J.-H., & Vemuganti, R. (2008). Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Frontiers in Bioscience: A Journal and Virtual Library, 13, 1813–1826.CrossRef

Kato, H., Tanaka, G., Masuda, S., Ogasawara, J., Sakurai, T., Kizaki, T., et al. (2015). Melatonin promotes adipogenesis and mitochondrial biogenesis in 3T3-L1 preadipocytes. Journal of Pineal Research, 59(2), 267–275. https://doi.org/10.1111/jpi.12259.PubMedCrossRef

Kaur, S. J., McKeown, S. R., & Rashid, S. (2016). Mutant SOD1 mediated pathogenesis of amyotrophic lateral sclerosis. Gene, 577(2), 109–118. https://doi.org/10.1016/j.gene.2015.11.049.PubMedCrossRef

Kawano, Y., & Kypta, R. (2003). Secreted antagonists of the Wnt signalling pathway. Journal of Cell Science, 116(Pt 13), 2627–2634. https://doi.org/10.1242/jcs.00623.PubMedCrossRef

Kiaei, M. (2008). Peroxisome proliferator-activated receptor-gamma in amyotrophic lateral sclerosis and Huntington’s disease. PPAR Research, 2008, 418765. https://doi.org/10.1155/2008/418765.PubMedPubMedCentralCrossRef

Kim, J., Gao, P., Liu, Y.-C., Semenza, G. L., & Dang, C. V. (2007). Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Molecular and Cellular Biology, 27(21), 7381–7393. https://doi.org/10.1128/mcb.00440-07.PubMedPubMedCentralCrossRef

Kim, G. H., Kim, J. E., Rhie, S. J., & Yoon, S. (2015). The role of oxidative stress in neurodegenerative diseases. Experimental Neurobiology, 24(4), 325–340. https://doi.org/10.5607/en.2015.24.4.325.PubMedPubMedCentralCrossRef

Kim, E. J., Kwon, K. J., Park, J. Y., Lee, S. H., Moon, C. H., & Baik, E. J. (2002). Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: Associated with iNOS and COX-2. Brain Research, 941(1–2), 1–10.PubMedCrossRef

Kim, W.-Y., & Snider, W. D. (2011). Functions of GSK-3 signaling in development of the nervous system. Frontiers in Molecular Neuroscience, 4, 44. https://doi.org/10.3389/fnmol.2011.00044.PubMedPubMedCentralCrossRef

Ko, C. H., & Takahashi, J. S. (2006). Molecular components of the mammalian circadian clock. Human Molecular Genetics, 15(2), 271–277. https://doi.org/10.1093/hmg/ddl207.CrossRef

Kondepudi, D., & Prigogine, I. (1999). Modern thermodynamics from heat engines to dissipative structures. New York: Willey.

Kondratova, A. A., & Kondratov, R. V. (2012). The circadian clock and pathology of the ageing brain. Nature Reviews Neuroscience, 13(5), 325–335. https://doi.org/10.1038/nrn3208.PubMedPubMedCentralCrossRef

Körner, S., Hendricks, M., Kollewe, K., Zapf, A., Dengler, R., Silani, V., et al. (2013). Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): Impact on quality of life and therapeutic options. BMC neurology, 13, 84. https://doi.org/10.1186/1471-2377-13-84.PubMedPubMedCentralCrossRef

Korvala, J., Jüppner, H., Mäkitie, O., Sochett, E., Schnabel, D., Mora, S., et al. (2012). Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity. BMC Medical Genetics, 13, 26. https://doi.org/10.1186/1471-2350-13-26.PubMedPubMedCentralCrossRef

Kott, J., Leach, G., & Yan, L. (2012). Direction-dependent effects of chronic “jet-lag” on hippocampal neurogenesis. Neuroscience Letters, 515(2), 177–180. https://doi.org/10.1016/j.neulet.2012.03.048.PubMedCrossRef

Krishnan, N., Davis, A. J., & Giebultowicz, J. M. (2008). Circadian regulation of response to oxidative stress in Drosophila melanogaster. Biochemical and Biophysical Research Communications, 374(2), 299–303. https://doi.org/10.1016/j.bbrc.2008.07.011.PubMedPubMedCentralCrossRef

Krishnan, N., Kretzschmar, D., Rakshit, K., Chow, E., & Giebultowicz, J. M. (2009). The circadian clock gene period extends healthspan in aging Drosophila melanogaster. Aging, 1(11), 937–948. https://doi.org/10.18632/aging.100103.PubMedPubMedCentralCrossRef

Kudo, T., Schroeder, A., Loh, D. H., Kuljis, D., Jordan, M. C., Roos, K. P., et al. (2011). Dysfunctions in circadian behavior and physiology in mouse models of Huntington’s disease. Experimental Neurology, 228(1), 80–90. https://doi.org/10.1016/j.expneurol.2010.12.011.PubMedCrossRef

Kuljis, D., Schroeder, A. M., Kudo, T., Loh, D. H., Willison, D. L., & Colwell, C. S. (2012). Sleep and circadian dysfunction in neurodegenerative disorders: insights from a mouse model of Huntington’s disease. Minerva Pneumologica, 51(3), 93–106.PubMedPubMedCentral

L’episcopo, F., Serapide, M. F., Tirolo, C., Testa, N., Caniglia, S., Morale, M. C., et al. (2011). A Wnt1 regulated Frizzled-1/β-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection. Molecular Neurodegeneration, 6, 49. https://doi.org/10.1186/1750-1326-6-49.PubMedPubMedCentralCrossRef

L’Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M. C., Deleidi, M., et al. (2012). Plasticity of subventricular zone neuroprogenitors in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson’s disease involves cross talk between inflammatory and Wnt/β-catenin signaling pathways: functional consequences for neuroprotection and repair. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 32(6), 2062–2085. https://doi.org/10.1523/jneurosci.5259-11.2012.CrossRef

Landreth, G., Jiang, Q., Mandrekar, S., & Heneka, M. (2008). PPARgamma agonists as therapeutics for the treatment of Alzheimer’s disease. Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics, 5(3), 481–489. https://doi.org/10.1016/j.nurt.2008.05.003.CrossRef

Lauretti, E., Di Meco, A., Merali, S., & Praticò, D. (2017). Circadian rhythm dysfunction: a novel environmental risk factor for Parkinson’s disease. Molecular Psychiatry, 22(2), 280–286. https://doi.org/10.1038/mp.2016.47.PubMedCrossRef

Lazar, A. S., Panin, F., Goodman, A. O. G., Lazic, S. E., Lazar, Z. I., Mason, S. L., et al. (2015). Sleep deficits but no metabolic deficits in premanifest Huntington’s disease. Annals of Neurology, 78(4), 630–648. https://doi.org/10.1002/ana.24495.PubMedPubMedCentralCrossRef

LeBlanc, J., & Ducharme, M. B. (2005). Influence of personality traits on plasma levels of cortisol and cholesterol. Physiology & Behavior, 84(5), 677–680. https://doi.org/10.1016/j.physbeh.2005.02.020.CrossRef

Lebreton, F., Cayzac, S., Pietropaolo, S., Jeantet, Y., & Cho, Y. H. (2015). Sleep physiology alterations precede plethoric phenotypic changes in R6/1 Huntington’s disease mice. PLoS ONE, 10(5), e0126972. https://doi.org/10.1371/journal.pone.0126972.PubMedPubMedCentralCrossRef

Lecarpentier, Y., Claes, V., Duthoit, G., & Hébert, J.-L. (2014). Circadian rhythms, Wnt/beta-catenin pathway and PPAR alpha/gamma profiles in diseases with primary or secondary cardiac dysfunction. Frontiers in Physiology, 5, 429. https://doi.org/10.3389/fphys.2014.00429.PubMedPubMedCentralCrossRef

Lecarpentier, Y., Claes, V., & Hébert, J.-L. (2010). PPARs, cardiovascular metabolism, and function: Near- or far-from-equilibrium pathways. PPAR research. https://doi.org/10.1155/2010/783273.PubMedPubMedCentralCrossRef

Lecarpentier, Y., Claes, V., Vallée, A., & Hébert, J.-L. (2017a). Interactions between PPAR gamma and the canonical Wnt/beta-catenin pathway in type 2 diabetes and colon cancer. PPAR Research, 2017, 1–9. https://doi.org/10.1155/2017/5879090.CrossRef

Lecarpentier, Y., Claes, V., Vallée, A., & Hébert, J.-L. (2017b). Thermodynamics in cancers: opposing interactions between PPAR gamma and the canonical WNT/beta-catenin pathway. Clinical and Translational Medicine, 6(1), 14. https://doi.org/10.1186/s40169-017-0144-7.PubMedPubMedCentralCrossRef

Lecarpentier, Y., & Vallée, A. (2016). Opposite Interplay between PPAR gamma and canonical Wnt/Beta-catenin pathway in amyotrophic lateral sclerosis. Frontiers in Neurology, 7, 100. https://doi.org/10.3389/fneur.2016.00100.PubMedPubMedCentralCrossRef

Lee, I.-K. (2014). The role of pyruvate dehydrogenase kinase in diabetes and obesity. Diabetes & Metabolism Journal, 38(3), 181–186. https://doi.org/10.4093/dmj.2014.38.3.181.CrossRef

Lee, M. W., Kim, D. S., Kim, H. R., Kim, H. J., Yang, J. M., Ryu, S., et al. (2012). Cell death is induced by ciglitazone, a peroxisome proliferator-activated receptor γ (PPARγ) agonist, independently of PPARγ in human glioma cells. Biochemical and Biophysical Research Communications, 417(1), 552–557. https://doi.org/10.1016/j.bbrc.2011.12.001.PubMedCrossRef

Lee, T. H., Pastorino, L., & Lu, K. P. (2011). Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease. Expert Reviews in Molecular Medicine, 13, e21. https://doi.org/10.1017/s1462399411001906.PubMedCrossRef

Leone, T. C., Lehman, J. J., Finck, B. N., Schaeffer, P. J., Wende, A. R., Boudina, S., et al. (2005). PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biology, 3(4), e101. https://doi.org/10.1371/journal.pbio.0030101.PubMedPubMedCentralCrossRef

Li, X.-H., Du, L.-L., Cheng, X.-S., Jiang, X., Zhang, Y., Lv, B.-L., et al. (2013). Glycation exacerbates the neuronal toxicity of β-amyloid. Cell Death and Disease, 4, e673. https://doi.org/10.1038/cddis.2013.180.PubMedPubMedCentralCrossRef

Li, H., Kang, T., Qi, B., Kong, L., Jiao, Y., Cao, Y., et al. (2016). Neuroprotective effects of ginseng protein on PI3K/Akt signaling pathway in the hippocampus of D-galactose/AlCl3 inducing rats model of Alzheimer’s disease. Journal of Ethnopharmacology, 179, 162–169. https://doi.org/10.1016/j.jep.2015.12.020.PubMedCrossRef

Libro, R., Bramanti, P., & Mazzon, E. (2016). The role of the Wnt canonical signaling in neurodegenerative diseases. Life Sciences, 158, 78–88. https://doi.org/10.1016/j.lfs.2016.06.024.PubMedCrossRef

Lim, A. S. P., Kowgier, M., Yu, L., Buchman, A. S., & Bennett, D. A. (2013a). Sleep fragmentation and the risk of incident Alzheimer’s disease and cognitive decline in older persons. Sleep, 36(7), 1027–1032. https://doi.org/10.5665/sleep.2802.PubMedPubMedCentralCrossRef

Lim, A. S. P., Yu, L., Kowgier, M., Schneider, J. A., Buchman, A. S., & Bennett, D. A. (2013b). Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA neurology, 70(12), 1544–1551. https://doi.org/10.1001/jamaneurol.2013.4215.PubMedCrossRef

Lin, F., Chen, Y., Li, X., Zhao, Q., & Tan, Z. (2013). Over-expression of circadian clock gene Bmal1 affects proliferation and the canonical Wnt pathway in NIH-3T3 cells. Cell Biochemistry and Function, 31(2), 166–172. https://doi.org/10.1002/cbf.2871.PubMedCrossRef

Lin, J., Wu, P.-H., Tarr, P. T., Lindenberg, K. S., St-Pierre, J., Zhang, C.-Y., et al. (2004). Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell, 119(1), 121–135. https://doi.org/10.1016/j.cell.2004.09.013.PubMedCrossRef

Liu, K., Li, F., Han, H., Chen, Y., Mao, Z., Luo, J., et al. (2016). Parkin regulates the activity of pyruvate kinase M2. The Journal of biological chemistry, 291(19), 10307–10317. https://doi.org/10.1074/jbc.m115.703066.PubMedPubMedCentralCrossRef

Liu, Y., Liu, F., Iqbal, K., Grundke-Iqbal, I., & Gong, C.-X. (2008). Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Letters, 582(2), 359–364. https://doi.org/10.1016/j.febslet.2007.12.035.PubMedPubMedCentralCrossRef

Liu, J., Wang, H., Zuo, Y., & Farmer, S. R. (2006). Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin. Molecular and Cellular Biology, 26(15), 5827–5837. https://doi.org/10.1128/mcb.00441-06.PubMedPubMedCentralCrossRef

Lo Coco, D., Mattaliano, P., Spataro, R., Mattaliano, A., & La Bella, V. (2011). Sleep-wake disturbances in patients with amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 82(8), 839–842. https://doi.org/10.1136/jnnp.2010.228007.PubMedCrossRef

Loewenstein, R. J., Weingartner, H., Gillin, J. C., Kaye, W., Ebert, M., & Mendelson, W. B. (1982). Disturbances of sleep and cognitive functioning in patients with dementia. Neurobiology of Aging, 3(4), 371–377.PubMedCrossRef

Loewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J. L., Bonenfant, D., et al. (2002). Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Molecular Cell, 10(3), 457–468.PubMedCrossRef

Lopes, C., Ribeiro, M., Duarte, A. I., Humbert, S., Saudou, F., Pereira de Almeida, L., et al. (2014). IGF-1 intranasal administration rescues Huntington’s disease phenotypes in YAC128 mice. Molecular Neurobiology, 49(3), 1126–1142. https://doi.org/10.1007/s12035-013-8585-5.PubMedCrossRef

Lu, K. P. (2004). Pinning down cell signaling, cancer and Alzheimer’s disease. Trends in Biochemical Sciences, 29(4), 200–209. https://doi.org/10.1016/j.tibs.2004.02.002.PubMedCrossRef

Lu, D., & Carson, D. A. (2010). Repression of beta-catenin signaling by PPAR gamma ligands. European Journal of Pharmacology, 636(1–3), 198–202. https://doi.org/10.1016/j.ejphar.2010.03.010.PubMedPubMedCentralCrossRef

Luna-Medina, R., Cortes-Canteli, M., Alonso, M., Santos, A., Martínez, A., & Perez-Castillo, A. (2005). Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation. The Journal of biological chemistry, 280(22), 21453–21462. https://doi.org/10.1074/jbc.m414390200.PubMedCrossRef

Luque-Contreras, D., Carvajal, K., Toral-Rios, D., Franco-Bocanegra, D., & Campos-Peña, V. (2014). Oxidative stress and metabolic syndrome: cause or consequence of Alzheimer’s disease? Oxidative Medicine and Cellular Longevity, 2014, 497802. https://doi.org/10.1155/2014/497802.PubMedPubMedCentralCrossRef

Lv, L., Li, D., Zhao, D., Lin, R., Chu, Y., Zhang, H., et al. (2011). Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth. Molecular Cell, 42(6), 719–730. https://doi.org/10.1016/j.molcel.2011.04.025.PubMedPubMedCentralCrossRef

Maguire-Zeiss, K. A., & Federoff, H. J. (2010). Future directions for immune modulation in neurodegenerative disorders: Focus on Parkinson’s disease. Journal of Neural Transmission (Vienna, Austria: 1996), 117(8), 1019–1025. https://doi.org/10.1007/s00702-010-0431-6.CrossRef

Manolopoulos, K. N., Klotz, L.-O., Korsten, P., Bornstein, S. R., & Barthel, A. (2010). Linking Alzheimer’s disease to insulin resistance: The FoxO response to oxidative stress. Molecular Psychiatry, 15(11), 1046–1052. https://doi.org/10.1038/mp.2010.17.PubMedCrossRef

Marchetti, B., & Pluchino, S. (2013). Wnt your brain be inflamed? Yes, it Wnt! Trends in Molecular Medicine, 19(3), 144–156. https://doi.org/10.1016/j.molmed.2012.12.001.PubMedPubMedCentralCrossRef

Marpegan, L., Swanstrom, A. E., Chung, K., Simon, T., Haydon, P. G., Khan, S. K., et al. (2011). Circadian regulation of ATP release in astrocytes. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 31(23), 8342–8350. https://doi.org/10.1523/jneurosci.6537-10.2011.CrossRef

Mattam, U., & Jagota, A. (2015). Daily rhythms of serotonin metabolism and the expression of clock genes in suprachiasmatic nucleus of rotenone-induced Parkinson’s disease male Wistar rat model and effect of melatonin administration. Biogerontology, 16(1), 109–123. https://doi.org/10.1007/s10522-014-9541-0.PubMedCrossRef

Mauriz, J. L., Collado, P. S., Veneroso, C., Reiter, R. J., & González-Gallego, J. (2013). A review of the molecular aspects of melatonin’s anti-inflammatory actions: Recent insights and new perspectives. Journal of Pineal Research, 54(1), 1–14. https://doi.org/10.1111/j.1600-079x.2012.01014.x.PubMedCrossRef

Maywood, E. S., Fraenkel, E., McAllister, C. J., Wood, N., Reddy, A. B., Hastings, M. H., et al. (2010). Disruption of peripheral circadian timekeeping in a mouse model of Huntington’s disease and its restoration by temporally scheduled feeding. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 30(30), 10199–10204. https://doi.org/10.1523/jneurosci.1694-10.2010.CrossRef

McEwen, B. S. (2000). The neurobiology of stress: From serendipity to clinical relevance. Brain Research, 886(1–2), 172–189.PubMedCrossRef

McEwen, B. S., & Reagan, L. P. (2004). Glucose transporter expression in the central nervous system: Relationship to synaptic function. European Journal of Pharmacology, 490(1–3), 13–24. https://doi.org/10.1016/j.ejphar.2004.02.041.PubMedCrossRef

Milakovic, T., & Johnson, G. V. W. (2005). Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin. The Journal of biological chemistry, 280(35), 30773–30782. https://doi.org/10.1074/jbc.m504749200.PubMedCrossRef

Miquel, E., Cassina, A., Martínez-Palma, L., Bolatto, C., Trías, E., Gandelman, M., et al. (2012). Modulation of astrocytic mitochondrial function by dichloroacetate improves survival and motor performance in inherited amyotrophic lateral sclerosis. PLoS ONE, 7(4), e34776. https://doi.org/10.1371/journal.pone.0034776.PubMedPubMedCentralCrossRef

Mizobuchi, M., Hineno, T., Kakimoto, Y., & Hiratani, K. (1993). Increase of plasma adrenocorticotrophin and cortisol in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated dogs. Brain Research, 612(1–2), 319–321.PubMedCrossRef

Mochel, F., & Haller, R. G. (2011). Energy deficit in Huntington disease: Why it matters. The Journal of Clinical Investigation, 121(2), 493–499. https://doi.org/10.1172/jci45691.PubMedPubMedCentralCrossRef

Moldes, M., Zuo, Y., Morrison, R. F., Silva, D., Park, B.-H., Liu, J., et al. (2003). Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis. The Biochemical Journal, 376(Pt 3), 607–613. https://doi.org/10.1042/bj20030426.PubMedPubMedCentralCrossRef

Mongrain, V., La Spada, F., Curie, T., & Franken, P. (2011). Sleep loss reduces the DNA-binding of BMAL1, CLOCK, and NPAS2 to specific clock genes in the mouse cerebral cortex. PLoS ONE, 6(10), e26622. https://doi.org/10.1371/journal.pone.0026622.PubMedPubMedCentralCrossRef

Morton, A. J., Wood, N. I., Hastings, M. H., Hurelbrink, C., Barker, R. A., & Maywood, E. S. (2005). Disintegration of the sleep-wake cycle and circadian timing in Huntington’s disease. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 25(1), 157–163. https://doi.org/10.1523/jneurosci.3842-04.2005.CrossRef

Mosconi, L., Pupi, A., & De Leon, M. J. (2008). Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer’s disease. Annals of the New York Academy of Sciences, 1147, 180–195. https://doi.org/10.1196/annals.1427.007.PubMedPubMedCentralCrossRef

Musiek, E. S. (2015). Circadian clock disruption in neurodegenerative diseases: Cause and effect? Frontiers in Pharmacology, 6, 29. https://doi.org/10.3389/fphar.2015.00029.PubMedPubMedCentralCrossRef

Musiek, E. S., Lim, M. M., Yang, G., Bauer, A. Q., Qi, L., Lee, Y., et al. (2013). Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration. The Journal of Clinical Investigation, 123(12), 5389–5400. https://doi.org/10.1172/jci70317.PubMedPubMedCentralCrossRef

Naia, L., Ferreira, I. L., Cunha-Oliveira, T., Duarte, A. I., Ribeiro, M., Rosenstock, T. R., et al. (2015). Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington’s Disease human lymphoblasts. Molecular Neurobiology, 51(1), 331–348. https://doi.org/10.1007/s12035-014-8735-4.PubMedCrossRef

Nakatsu, Y., Matsunaga, Y., Yamamotoya, T., Ueda, K., Inoue, Y., Mori, K., et al. (2016). Physiological and pathogenic roles of prolyl isomerase Pin1 in metabolic regulations via multiple signal transduction pathway modulations. International Journal of Molecular Sciences, 17(9), 1495. https://doi.org/10.3390/ijms17091495.PubMedCentralCrossRef

Napoli, E., Wong, S., Hung, C., Ross-Inta, C., Bomdica, P., & Giulivi, C. (2013). Defective mitochondrial disulfide relay system, altered mitochondrial morphology and function in Huntington’s disease. Human Molecular Genetics, 22(5), 989–1004. https://doi.org/10.1093/hmg/dds503.PubMedCrossRef

Nenov, M. N., Laezza, F., Haidacher, S. J., Zhao, Y., Sadygov, R. G., Starkey, J. M., et al. (2014). Cognitive enhancing treatment with a PPARγ agonist normalizes dentate granule cell presynaptic function in Tg2576 APP mice. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 34(3), 1028–1036. https://doi.org/10.1523/jneurosci.3413-13.2014.CrossRef

Neves, A., Costalat, R., & Pellerin, L. (2012). Determinants of brain cell metabolic phenotypes and energy substrate utilization unraveled with a modeling approach. PLoS Computational Biology, 8(9), e1002686. https://doi.org/10.1371/journal.pcbi.1002686.PubMedPubMedCentralCrossRef

Newington, J. T., Pitts, A., Chien, A., Arseneault, R., Schubert, D., & Cumming, R. C. (2011). Amyloid beta resistance in nerve cell lines is mediated by the Warburg effect. PLoS ONE, 6(4), e19191. https://doi.org/10.1371/journal.pone.0019191.PubMedPubMedCentralCrossRef

Newington, J. T., Rappon, T., Albers, S., Wong, D. Y., Rylett, R. J., & Cumming, R. C. (2012). Overexpression of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase A in nerve cells confers resistance to amyloid β and other toxins by decreasing mitochondrial respiration and reactive oxygen species production. The Journal of biological chemistry, 287(44), 37245–37258. https://doi.org/10.1074/jbc.m112.366195.PubMedPubMedCentralCrossRef

Nicolakakis, N., & Hamel, E. (2010). The nuclear receptor PPARgamma as a therapeutic target for cerebrovascular and brain dysfunction in Alzheimer’s disease. Frontiers in Aging Neuroscience. https://doi.org/10.3389/fnagi.2010.00021.PubMedPubMedCentralCrossRef

Nicolis, G., & Prigogine, I. (1971). Fluctuations in nonequilibrium systems. Proceedings of the National Academy of Sciences of the United States of America, 68(9), 2102–2107.PubMedPubMedCentralCrossRef

Niida, A., Hiroko, T., Kasai, M., Furukawa, Y., Nakamura, Y., Suzuki, Y., et al. (2004). DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene, 23(52), 8520–8526. https://doi.org/10.1038/sj.onc.1207892.PubMedCrossRef

Nir, Y., Staba, R. J., Andrillon, T., Vyazovskiy, V. V., Cirelli, C., Fried, I., et al. (2011). Regional slow waves and spindles in human sleep. Neuron, 70(1), 153–169. https://doi.org/10.1016/j.neuron.2011.02.043.PubMedPubMedCentralCrossRef

Obel, L. F., Müller, M. S., Walls, A. B., Sickmann, H. M., Bak, L. K., Waagepetersen, H. S., et al. (2012). Brain glycogen-new perspectives on its metabolic function and regulation at the subcellular level. Frontiers in Neuroenergetics, 4, 3. https://doi.org/10.3389/fnene.2012.00003.PubMedPubMedCentralCrossRef

Olcese, J. M., Cao, C., Mori, T., Mamcarz, M. B., Maxwell, A., Runfeldt, M. J., et al. (2009). Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. Journal of Pineal Research, 47(1), 82–96. https://doi.org/10.1111/j.1600-079x.2009.00692.x.PubMedCrossRef

Oliva, C. A., Vargas, J. Y., & Inestrosa, N. C. (2013). Wnts in adult brain: From synaptic plasticity to cognitive deficiencies. Frontiers in Cellular Neuroscience, 7, 224. https://doi.org/10.3389/fncel.2013.00224.PubMedPubMedCentralCrossRef

Orellana, A. M. M., Vasconcelos, A. R., Leite, J. A., de Sá Lima, L., Andreotti, D. Z., Munhoz, C. D., et al. (2015). Age-related neuroinflammation and changes in AKT-GSK-3β and WNT/β-CATENIN signaling in rat hippocampus. Aging, 7(12), 1094–1111. https://doi.org/10.18632/aging.100853.PubMedPubMedCentralCrossRef

Oz, G., Seaquist, E. R., Kumar, A., Criego, A. B., Benedict, L. E., Rao, J. P., et al. (2007). Human brain glycogen content and metabolism: implications on its role in brain energy metabolism. American Journal of Physiology. Endocrinology and metabolism, 292(3), E946–E951. https://doi.org/10.1152/ajpendo.00424.2006.PubMedCrossRef

Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., et al. (2004). Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. The Journal of Biological Chemistry, 279(18), 18614–18622. https://doi.org/10.1074/jbc.m401135200.PubMedCrossRef

Panaccione, I., Napoletano, F., Forte, A. M., Kotzalidis, G. D., Del Casale, A., Rapinesi, C., et al. (2013). Neurodevelopment in schizophrenia: The role of the wnt pathways. Current Neuropharmacology, 11(5), 535–558. https://doi.org/10.2174/1570159x113119990037.PubMedPubMedCentralCrossRef

Parekh, P. K., Ozburn, A. R., & McClung, C. A. (2015). Circadian clock genes: effects on dopamine, reward and addiction. Alcohol (Fayetteville, N.Y.), 49(4), 341–349. https://doi.org/10.1016/j.alcohol.2014.09.034.CrossRef

Parish, C. L., Castelo-Branco, G., Rawal, N., Tonnesen, J., Sorensen, A. T., Salto, C., et al. (2008). Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice. The Journal of Clinical Investigation, 118(1), 149–160. https://doi.org/10.1172/jci32273.PubMedCrossRef

Park, K. S., Lee, R. D., Kang, S.-K., Han, S. Y., Park, K. L., Yang, K. H., et al. (2004). Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway. Experimental Cell Research, 297(2), 424–433. https://doi.org/10.1016/j.yexcr.2004.03.034.PubMedCrossRef

Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., et al. (2005). A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature, 437(7059), 759–763. https://doi.org/10.1038/nature03988.PubMedPubMedCentralCrossRef

Pate, K. T., Stringari, C., Sprowl-Tanio, S., Wang, K., TeSlaa, T., Hoverter, N. P., et al. (2014). Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer. The EMBO journal, 33(13), 1454–1473. https://doi.org/10.15252/embj.201488598.PubMedPubMedCentralCrossRef

Patel, A. B., Lai, J. C. K., Chowdhury, G. M. I., Hyder, F., Rothman, D. L., Shulman, R. G., et al. (2014). Direct evidence for activity-dependent glucose phosphorylation in neurons with implications for the astrocyte-to-neuron lactate shuttle. Proceedings of the National Academy of Sciences of the United States of America, 111(14), 5385–5390. https://doi.org/10.1073/pnas.1403576111.PubMedPubMedCentralCrossRef

Pellerin, L., & Magistretti, P. J. (2012). Sweet sixteen for ANLS. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 32(7), 1152–1166. https://doi.org/10.1038/jcbfm.2011.149.CrossRef

Pesah, Y., Pham, T., Burgess, H., Middlebrooks, B., Verstreken, P., Zhou, Y., et al. (2004). Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development (Cambridge, England), 131(9), 2183–2194. https://doi.org/10.1242/dev.01095.CrossRef

Peter-Derex, L., Yammine, P., Bastuji, H., & Croisile, B. (2015). Sleep and Alzheimer’s disease. Sleep Medicine Reviews, 19, 29–38. https://doi.org/10.1016/j.smrv.2014.03.007.PubMedCrossRef

Pevet, P., & Challet, E. (2011). Melatonin: Both master clock output and internal time-giver in the circadian clocks network. Journal of Physiology, Paris, 105(4–6), 170–182. https://doi.org/10.1016/j.jphysparis.2011.07.001.PubMedCrossRef

Piccini, P., Del Dotto, P., Pardini, C., D’Antonio, P., Rossi, G., & Bonuccelli, U. (1991). Diurnal worsening in Parkinson patients treated with levodopa. Rivista Di Neurologia, 61(6), 219–224.PubMed

Pinto, M., Nissanka, N., Peralta, S., Brambilla, R., Diaz, F., & Moraes, C. T. (2016). Pioglitazone ameliorates the phenotype of a novel Parkinson’s disease mouse model by reducing neuroinflammation. Molecular Neurodegeneration, 11, 25. https://doi.org/10.1186/s13024-016-0090-7.PubMedPubMedCentralCrossRef

Prigogine, I. (1986). Life and physics. New perspectives. Cell Biophysics, 9(1–2), 217–224. https://doi.org/10.1007/bf02797383.PubMedCrossRef

Prigogine, I., & Nicolis, G. (1971). Biological order, structure and instabilities. Quarterly Reviews of Biophysics, 4(2), 107–148.PubMedCrossRef

Prigogine, I., Nicolis, G., & Babloyantz, A. (1974). Nonequilibrium problems in biological phenomena. Annals of the New York Academy of Sciences, 231(1), 99–105.PubMedCrossRef

Purro, S. A., Dickins, E. M., & Salinas, P. C. (2012). The secreted Wnt antagonist Dickkopf-1 is required for amyloid β-mediated synaptic loss. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 32(10), 3492–3498. https://doi.org/10.1523/jneurosci.4562-11.2012.CrossRef

Quan, Q., Wang, J., Li, X., & Wang, Y. (2013). Ginsenoside Rg1 decreases Aβ(1-42) level by upregulating PPARγ and IDE expression in the hippocampus of a rat model of Alzheimer’s disease. PLoS ONE, 8(3), e59155. https://doi.org/10.1371/journal.pone.0059155.PubMedPubMedCentralCrossRef

Rakshit, K., & Giebultowicz, J. M. (2013). Cryptochrome restores dampened circadian rhythms and promotes healthspan in aging Drosophila. Aging Cell, 12(5), 752–762. https://doi.org/10.1111/acel.12100.PubMedCrossRef

Ramos, M., del Arco, A., Pardo, B., Martínez-Serrano, A., Martínez-Morales, J. R., Kobayashi, K., et al. (2003). Developmental changes in the Ca2+-regulated mitochondrial aspartate-glutamate carrier aralar1 in brain and prominent expression in the spinal cord. Brain Research. Developmental Brain Research, 143(1), 33–46.PubMedCrossRef

Rani, N., Bharti, S., Bhatia, J., Nag, T. C., Ray, R., & Arya, D. S. (2016). Chrysin, a PPAR-γ agonist improves myocardial injury in diabetic rats through inhibiting AGE-RAGE mediated oxidative stress and inflammation. Chemico-Biological Interactions, 250, 59–67. https://doi.org/10.1016/j.cbi.2016.03.015.PubMedCrossRef

Rawal, N., Corti, O., Sacchetti, P., Ardilla-Osorio, H., Sehat, B., Brice, A., et al. (2009). Parkin protects dopaminergic neurons from excessive Wnt/beta-catenin signaling. Biochemical and Biophysical Research Communications, 388(3), 473–478. https://doi.org/10.1016/j.bbrc.2009.07.014.PubMedCrossRef

Reppert, S. M., & Weaver, D. R. (2002). Coordination of circadian timing in mammals. Nature, 418(6901), 935–941. https://doi.org/10.1038/nature00965.PubMedCrossRef

Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010). Oxidative stress, inflammation, and cancer: How are they linked? Free Radical Biology and Medicine, 49(11), 1603–1616. https://doi.org/10.1016/j.freeradbiomed.2010.09.006.PubMedCrossRef

Ricote, M., & Glass, C. K. (2007). PPARs and molecular mechanisms of transrepression. Biochimica et Biophysica Acta, 1771(8), 926–935. https://doi.org/10.1016/j.bbalip.2007.02.013.PubMedPubMedCentralCrossRef

Riggs, J. E. (1998). Aging, increasing genomic entropy, and neurodegenerative disease. Neurologic Clinics, 16(3), 757–770.PubMedCrossRef

Roche, T. E., Baker, J. C., Yan, X., Hiromasa, Y., Gong, X., Peng, T., et al. (2001). Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms. Progress in Nucleic Acid Research and Molecular Biology, 70, 33–75.PubMedCrossRef

Roh, J. H., Huang, Y., Bero, A. W., Kasten, T., Stewart, F. R., Bateman, R. J., et al. (2012). Disruption of the sleep-wake cycle and diurnal fluctuation of β-amyloid in mice with Alzheimer’s disease pathology. Science Translational Medicine, 4(150), 150ra122. https://doi.org/10.1126/scitranslmed.3004291.PubMedPubMedCentralCrossRef

Rong, J. X., Klein, J.-L. D., Qiu, Y., Xie, M., Johnson, J. H., Waters, K. M., et al. (2011). Rosiglitazone induces mitochondrial biogenesis in differentiated murine 3T3-L1 and C3H/10T1/2 adipocytes. PPAR Research, 2011, 179454. https://doi.org/10.1155/2011/179454.PubMedPubMedCentralCrossRef

Rosales-Corral, S. A., Acuña-Castroviejo, D., Coto-Montes, A., Boga, J. A., Manchester, L. C., Fuentes-Broto, L., et al. (2012). Alzheimer’s disease: Pathological mechanisms and the beneficial role of melatonin. Journal of Pineal Research, 52(2), 167–202. https://doi.org/10.1111/j.1600-079x.2011.00937.x.PubMedCrossRef

Rosi, M. C., Luccarini, I., Grossi, C., Fiorentini, A., Spillantini, M. G., Prisco, A., et al. (2010). Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease. Journal of Neurochemistry, 112(6), 1539–1551. https://doi.org/10.1111/j.1471-4159.2009.06566.x.PubMedCrossRef

Ryu, H., Rosas, H. D., Hersch, S. M., & Ferrante, R. J. (2005). The therapeutic role of creatine in Huntington’s disease. Pharmacology & Therapeutics, 108(2), 193–207. https://doi.org/10.1016/j.pharmthera.2005.04.008.CrossRef

Sahar, S., & Sassone-Corsi, P. (2009). Metabolism and cancer: the circadian clock connection. Nature Reviews Cancer, 9(12), 886–896. https://doi.org/10.1038/nrc2747.PubMedCrossRef

Salinas, P. C. (2012). Wnt signaling in the vertebrate central nervous system: From axon guidance to synaptic function. Cold Spring Harbor Perspectives in Biology. https://doi.org/10.1101/cshperspect.a008003.PubMedPubMedCentralCrossRef

Sameni, S., Syed, A., Marsh, J. L., & Digman, M. A. (2016). The phasor-FLIM fingerprints reveal shifts from OXPHOS to enhanced glycolysis in Huntington Disease. Scientific Reports, 6, 34755. https://doi.org/10.1038/srep34755.PubMedPubMedCentralCrossRef

Sancar, A., Lindsey-Boltz, L. A., Unsal-Kaçmaz, K., & Linn, S. (2004). Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annual Review of Biochemistry, 73, 39–85. https://doi.org/10.1146/annurev.biochem.73.011303.073723.PubMedCrossRef

Sandler, S. (2006). Chemical and engineering thermodynamics (4th ed.). New-York: Wiely.

Schapira, A. H. V. (2008). Mitochondria in the aetiology and pathogenesis of Parkinson’s disease. The Lancet Neurology, 7(1), 97–109. https://doi.org/10.1016/s1474-4422(07)70327-7.PubMedCrossRef

Schibler, U., & Sassone-Corsi, P. (2002). A web of circadian pacemakers. Cell, 111(7), 919–922.PubMedCrossRef

Schmidt, M., Fernandez de Mattos, S., van der Horst, A., Klompmaker, R., Kops, G. J. P. L., Lam, E. W.-F., et al. (2002). Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Molecular and Cellular Biology, 22(22), 7842–7852.PubMedPubMedCentralCrossRef

Schnell, A., Chappuis, S., Schmutz, I., Brai, E., Ripperger, J. A., Schaad, O., et al. (2014). The nuclear receptor REV-ERBα regulates Fabp7 and modulates adult hippocampal neurogenesis. PLoS ONE, 9(6), e99883. https://doi.org/10.1371/journal.pone.0099883.PubMedPubMedCentralCrossRef

Schreiber, S. L. (1991). Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science (New York, N.Y.), 251(4991), 283–287.CrossRef

Schubert, D. (2005). Glucose metabolism and Alzheimer’s disease. Ageing Research Reviews, 4(2), 240–257. https://doi.org/10.1016/j.arr.2005.02.003.PubMedCrossRef

Schurr, A. (2014). Cerebral glycolysis: A century of persistent misunderstanding and misconception. Frontiers in Neuroscience, 8, 360. https://doi.org/10.3389/fnins.2014.00360.PubMedPubMedCentralCrossRef

Scuderi, C., Steardo, L., & Esposito, G. (2014). Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPARγ involvement. Phytotherapy Research: PTR, 28(7), 1007–1013. https://doi.org/10.1002/ptr.5095.PubMedCrossRef

Semënov, M. V., Zhang, X., & He, X. (2008). DKK1 antagonizes Wnt signaling without promotion of LRP6 internalization and degradation. The Journal of biological chemistry, 283(31), 21427–21432. https://doi.org/10.1074/jbc.m800014200.PubMedPubMedCentralCrossRef

Semenza, G. L. (2010). HIF-1: Upstream and downstream of cancer metabolism. Current Opinion in Genetics & Development, 20(1), 51–56. https://doi.org/10.1016/j.gde.2009.10.009.CrossRef

Seong, I. S., Ivanova, E., Lee, J.-M., Choo, Y. S., Fossale, E., Anderson, M., et al. (2005). HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. Human Molecular Genetics, 14(19), 2871–2880. https://doi.org/10.1093/hmg/ddi319.PubMedCrossRef

Shang, Y. C., Chong, Z. Z., Hou, J., & Maiese, K. (2009). The forkhead transcription factor FOXO3a controls microglial inflammatory activation and eventual apoptotic injury through caspase 3. Current Neurovascular Research, 6(1), 20–31.PubMedPubMedCentralCrossRef

Shang, Y. C., Chong, Z. Z., Hou, J., & Maiese, K. (2010). Wnt1, FoxO3a, and NF-kappaB oversee microglial integrity and activation during oxidant stress. Cellular Signalling, 22(9), 1317–1329. https://doi.org/10.1016/j.cellsig.2010.04.009.PubMedPubMedCentralCrossRef

Sharma, C., Pradeep, A., Wong, L., Rana, A., & Rana, B. (2004). Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway. The Journal of biological chemistry, 279(34), 35583–35594. https://doi.org/10.1074/jbc.m403143200.PubMedCrossRef

Shimizu, T., Uchida, C., Shimizu, R., Motohashi, H., & Uchida, T. (2017). Prolyl isomerase Pin1 promotes proplatelet formation of megakaryocytes via tau. Biochemical and Biophysical Research Communications, 493(2), 946–951. https://doi.org/10.1016/j.bbrc.2017.09.115.PubMedCrossRef

Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., et al. (1999). The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proceedings of the National Academy of Sciences of the United States of America, 96(10), 5522–5527.PubMedPubMedCentralCrossRef

Siersbæk, M. S., Loft, A., Aagaard, M. M., Nielsen, R., Schmidt, S. F., Petrovic, N., et al. (2012). Genome-wide profiling of peroxisome proliferator-activated receptor γ in primary epididymal, inguinal, and brown adipocytes reveals depot-selective binding correlated with gene expression. Molecular and Cellular Biology, 32(17), 3452–3463. https://doi.org/10.1128/mcb.00526-12.PubMedPubMedCentralCrossRef

Simpson, I. A., Carruthers, A., & Vannucci, S. J. (2007). Supply and demand in cerebral energy metabolism: The role of nutrient transporters. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 27(11), 1766–1791. https://doi.org/10.1038/sj.jcbfm.9600521.CrossRef

Skene, D. J., & Swaab, D. F. (2003). Melatonin rhythmicity: effect of age and Alzheimer’s disease. Experimental Gerontology, 38(1–2), 199–206.PubMedCrossRef

Sochocka, M., Koutsouraki, E. S., Gasiorowski, K., & Leszek, J. (2013). Vascular oxidative stress and mitochondrial failure in the pathobiology of Alzheimer’s disease: A new approach to therapy. CNS & Neurological Disorders: Drug Targets, 12(6), 870–881.CrossRef

Song, H., Moon, M., Choe, H. K., Han, D.-H., Jang, C., Kim, A., et al. (2015). Aβ-induced degradation of BMAL1 and CBP leads to circadian rhythm disruption in Alzheimer’s disease. Molecular Neurodegeneration. https://doi.org/10.1186/s13024-015-0007-x.CrossRefPubMedPubMedCentral

Soták, M., Sumová, A., & Pácha, J. (2014). Cross-talk between the circadian clock and the cell cycle in cancer. Annals of Medicine, 46(4), 221–232. https://doi.org/10.3109/07853890.2014.892296.PubMedCrossRef

Soucek, T., Cumming, R., Dargusch, R., Maher, P., & Schubert, D. (2003). The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron, 39(1), 43–56.PubMedCrossRef

Spataro, R., Volanti, P., Vitale, F., Meli, F., Colletti, T., Di Natale, A., et al. (2015). Plasma cortisol level in amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 358(1–2), 282–286. https://doi.org/10.1016/j.jns.2015.09.011.PubMedCrossRef

Stahl, M., Dijkers, P. F., Kops, G. J. P. L., Lens, S. M. A., Coffer, P. J., Burgering, B. M. T., et al. (2002). The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. Journal of Immunology (Baltimore, Md.: 1950), 168(10), 5024–5031.CrossRef

Sterniczuk, R., Theou, O., Rusak, B., & Rockwood, K. (2013). Sleep disturbance is associated with incident dementia and mortality. Current Alzheimer Research, 10(7), 767–775.PubMedCrossRef

Stobart, J. L., & Anderson, C. M. (2013). Multifunctional role of astrocytes as gatekeepers of neuronal energy supply. Frontiers in Cellular Neuroscience, 7, 38. https://doi.org/10.3389/fncel.2013.00038.PubMedPubMedCentralCrossRef

St-Pierre, J., Lin, J., Krauss, S., Tarr, P. T., Yang, R., Newgard, C. B., et al. (2003). Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. The Journal of biological chemistry, 278(29), 26597–26603. https://doi.org/10.1074/jbc.m301850200.PubMedCrossRef

Struck, L. K., Rodnitzky, R. L., & Dobson, J. K. (1990). Circadian fluctuations of contrast sensitivity in Parkinson’s disease. Neurology, 40(3 Pt 1), 467–470.PubMedCrossRef

Strum, J. C., Shehee, R., Virley, D., Richardson, J., Mattie, M., Selley, P., et al. (2007). Rosiglitazone induces mitochondrial biogenesis in mouse brain. Journal of Alzheimer’s disease: JAD, 11(1), 45–51.PubMedCrossRef

Sun, Q., Chen, X., Ma, J., Peng, H., Wang, F., Zha, X., et al. (2011). Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth. Proceedings of the National Academy of Sciences of the United States of America, 108(10), 4129–4134. https://doi.org/10.1073/pnas.1014769108.PubMedPubMedCentralCrossRef

Synofzik, M., Ronchi, D., Keskin, I., Basak, A. N., Wilhelm, C., Gobbi, C., et al. (2012). Mutant superoxide dismutase-1 indistinguishable from wild-type causes ALS. Human Molecular Genetics, 21(16), 3568–3574. https://doi.org/10.1093/hmg/dds188.PubMedCrossRef

Szablewski, L. (2017). Glucose transporters in brain: In health and in Alzheimer’s disease. Journal of Alzheimer’s disease: JAD, 55(4), 1307–1320. https://doi.org/10.3233/jad-160841.PubMedCrossRef

Takada, I., Kouzmenko, A. P., & Kato, S. (2009). Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis. Nature Reviews Rheumatology, 5(8), 442–447. https://doi.org/10.1038/nrrheum.2009.137.PubMedCrossRef

Tefera, T. W., Tan, K. N., McDonald, T. S., & Borges, K. (2016). Alternative fuels in epilepsy and amyotrophic lateral sclerosis. Neurochemical Research. https://doi.org/10.1007/s11064-016-2106-7.PubMedCrossRef

Thies, W. (2011). Stopping a thief and killer: Alzheimer’s disease crisis demands greater commitment to research. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 7(2), 175–176. https://doi.org/10.1016/j.jalz.2011.02.002.CrossRef

Thomas, B., & Beal, M. F. (2007). Parkinson’s disease. Human Molecular Genetics, 16(2), R183–R194. https://doi.org/10.1093/hmg/ddm159.PubMedCrossRef

Thompson, C. B. (2014). Wnt meets Warburg: Another piece in the puzzle? The EMBO journal, 33(13), 1420–1422. https://doi.org/10.15252/embj.201488785.PubMedPubMedCentralCrossRef

Tillement, L., Lecanu, L., & Papadopoulos, V. (2011). Further evidence on mitochondrial targeting of β-amyloid and specificity of β-amyloid-induced mitotoxicity in neurons. Neuro-Degenerative Diseases, 8(5), 331–344. https://doi.org/10.1159/000323264.PubMedCrossRef

Tsunemi, T., Ashe, T. D., Morrison, B. E., Soriano, K. R., Au, J., Roque, R. A. V., et al. (2012). PGC-1α rescues Huntington’s disease proteotoxicity by preventing oxidative stress and promoting TFEB function. Science Translational Medicine, 4(142), 142–197. https://doi.org/10.1126/scitranslmed.3003799.CrossRef

Vaishnavi, S. N., Vlassenko, A. G., Rundle, M. M., Snyder, A. Z., Mintun, M. A., & Raichle, M. E. (2010). Regional aerobic glycolysis in the human brain. Proceedings of the National Academy of Sciences of the United States of America, 107(41), 17757–17762. https://doi.org/10.1073/pnas.1010459107.PubMedPubMedCentralCrossRef

Valbuena, G. N., Rizzardini, M., Cimini, S., Siskos, A. P., Bendotti, C., Cantoni, L., et al. (2016). Metabolomic analysis reveals increased aerobic glycolysis and amino acid deficit in a cellular model of amyotrophic lateral sclerosis. Molecular Neurobiology, 53(4), 2222–2240. https://doi.org/10.1007/s12035-015-9165-7.PubMedCrossRef

Vallée, A., Guillevin, R., & Vallée, J.-N. (2018a). Vasculogenesis and angiogenesis initiation under normoxic conditions through Wnt/β-catenin pathway in gliomas. Reviews in the Neurosciences, 29(1), 71–91. https://doi.org/10.1515/revneuro-2017-0032.PubMedCrossRef

Vallée, A., & Lecarpentier, Y. (2016). Alzheimer disease: Crosstalk between the canonical Wnt/beta-catenin pathway and PPARs alpha and gamma. Frontiers in Neuroscience, 10, 459. https://doi.org/10.3389/fnins.2016.00459.PubMedPubMedCentralCrossRef

Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017a). Thermodynamics in gliomas: Interactions between the Canonical WNT/beta-catenin pathway and PPAR gamma. Frontiers in Physiology, 8, 352. https://doi.org/10.3389/fphys.2017.00352.PubMedPubMedCentralCrossRef

Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017b). Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis. Oncotarget, 8(52), 90579–90604. https://doi.org/10.18632/oncotarget.21234.PubMedPubMedCentralCrossRef

Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017c). PPARγ agonists: Potential treatments for exudative age-related macular degeneration. Life Sciences, 188, 123–130. https://doi.org/10.1016/j.lfs.2017.09.008.PubMedCrossRef

Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017d). Aerobic glycolysis hypothesis through WNT/beta-catenin pathway in exudative age-related macular degeneration. Journal of Molecular Neuroscience: MN, 62(3–4), 368–379. https://doi.org/10.1007/s12031-017-0947-4.PubMedCrossRef

Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017e). Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer’s disease. Acta Biochimica et Biophysica Sinica, 49(10), 853–866. https://doi.org/10.1093/abbs/gmx073.PubMedCrossRef

Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2018b). Aerobic glycolysis in amyotrophic lateral sclerosis and Huntington’s disease. Reviews in the Neurosciences. https://doi.org/10.1515/revneuro-2017-0075.CrossRefPubMed

Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2018c). Reprogramming energetic metabolism in Alzheimer’s disease. Life Sciences, 193, 141–152. https://doi.org/10.1016/j.lfs.2017.10.033.PubMedCrossRef

Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2017f). Thermodynamic aspects and reprogramming cellular energy metabolism during the fibrosis process. International Journal of Molecular Sciences, 18(12), 2537. https://doi.org/10.3390/ijms18122537.PubMedCentralCrossRef

Vallée, A., Vallée, J.-N., Guillevin, R., & Lecarpentier, Y. (2017g). Interactions between the canonical WNT/beta-catenin pathway and PPAR gamma on neuroinflammation, demyelination, and remyelination in multiple sclerosis. Cellular and Molecular Neurobiology. https://doi.org/10.1007/s10571-017-0550-9.PubMedCrossRef

Valvezan, A. J., & Klein, P. S. (2012). GSK-3 and Wnt signaling in neurogenesis and bipolar disorder. Frontiers in Molecular Neuroscience, 5, 1. https://doi.org/10.3389/fnmol.2012.00001.PubMedPubMedCentralCrossRef

van Wamelen, D. J., Aziz, N. A., Anink, J. J., van Steenhoven, R., Angeloni, D., Fraschini, F., et al. (2013). Suprachiasmatic nucleus neuropeptide expression in patients with Huntington’s Disease. Sleep, 36(1), 117–125. https://doi.org/10.5665/sleep.2314.PubMedPubMedCentralCrossRef

Videnovic, A., & Golombek, D. (2013). Circadian and sleep disorders in Parkinson’s disease. Experimental Neurology, 243, 45–56. https://doi.org/10.1016/j.expneurol.2012.08.018.PubMedCrossRef

Videnovic, A., & Willis, G. L. (2016). Circadian system—A novel diagnostic and therapeutic target in Parkinson’s disease? Movement Disorders: Official Journal of the Movement Disorder Society, 31(3), 260–269. https://doi.org/10.1002/mds.26509.CrossRef

Videnovic, A., & Zee, P. C. (2015). Consequences of circadian disruption on neurologic health. Sleep Medicine Clinics, 10(4), 469–480. https://doi.org/10.1016/j.jsmc.2015.08.004.PubMedPubMedCentralCrossRef

Vlassenko, A. G., Vaishnavi, S. N., Couture, L., Sacco, D., Shannon, B. J., Mach, R. H., et al. (2010). Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition. Proceedings of the National Academy of Sciences of the United States of America, 107(41), 17763–17767. https://doi.org/10.1073/pnas.1010461107.PubMedPubMedCentralCrossRef

Wan, W., Xia, S., Kalionis, B., Liu, L., & Li, Y. (2014). The role of Wnt signaling in the development of Alzheimer’s disease: A potential therapeutic target? BioMed Research International, 2014, 301575. https://doi.org/10.1155/2014/301575.PubMedPubMedCentralCrossRef

Wang, S., Guan, Y., Chen, Y., Li, X., Zhang, C., Yu, L., et al. (2013). Role of Wnt1 and Fzd1 in the spinal cord pathogenesis of amyotrophic lateral sclerosis-transgenic mice. Biotechnology Letters, 35(8), 1199–1207. https://doi.org/10.1007/s10529-013-1199-1.PubMedCrossRef

Wang, Q., Liu, Y., & Zhou, J. (2015). Neuroinflammation in Parkinson’s disease and its potential as therapeutic target. Translational Neurodegeneration, 4, 19. https://doi.org/10.1186/s40035-015-0042-0.PubMedPubMedCentralCrossRef

Wang, X., Sirianni, A., Pei, Z., Cormier, K., Smith, K., Jiang, J., et al. (2011). The melatonin MT1 receptor axis modulates mutant Huntingtin-mediated toxicity. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 31(41), 14496–14507. https://doi.org/10.1523/jneurosci.3059-11.2011.CrossRef

Wang, X., Wang, Y., Hu, J.-P., Yu, S., Li, B.-K., Cui, Y., et al. (2017). Astragaloside IV, a natural PPARγ agonist, reduces Aβ production in Alzheimer’s disease through inhibition of BACE1. Molecular Neurobiology, 54(4), 2939–2949. https://doi.org/10.1007/s12035-016-9874-6.PubMedCrossRef

Wang, N., Yang, G., Jia, Z., Zhang, H., Aoyagi, T., Soodvilai, S., et al. (2008). Vascular PPARgamma controls circadian variation in blood pressure and heart rate through Bmal1. Cell Metabolism, 8(6), 482–491. https://doi.org/10.1016/j.cmet.2008.10.009.PubMedPubMedCentralCrossRef

Wang, H.-M., Zhao, Y.-X., Zhang, S., Liu, G.-D., Kang, W.-Y., Tang, H.-D., et al. (2010). PPARgamma agonist curcumin reduces the amyloid-beta-stimulated inflammatory responses in primary astrocytes. Journal of Alzheimer’s disease: JAD, 20(4), 1189–1199. https://doi.org/10.3233/jad-2010-091336.PubMedCrossRef

Warburg, O. (1956). On the origin of cancer cells. Science (New York, N.Y.), 123(3191), 309–314.CrossRef

Weishaupt, J. H., Bartels, C., Pölking, E., Dietrich, J., Rohde, G., Poeggeler, B., et al. (2006). Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. Journal of Pineal Research, 41(4), 313–323. https://doi.org/10.1111/j.1600-079X.2006.00377.x.PubMedCrossRef

Wenz, T., Diaz, F., Spiegelman, B. M., & Moraes, C. T. (2008). Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metabolism, 8(3), 249–256. https://doi.org/10.1016/j.cmet.2008.07.006.PubMedPubMedCentralCrossRef

Wiedau-Pazos, M., Wong, E., Solomon, E., Alarcon, M., & Geschwind, D. H. (2009). Wnt-pathway activation during the early stage of neurodegeneration in FTDP-17 mice. Neurobiology of Aging, 30(1), 14–21. https://doi.org/10.1016/j.neurobiolaging.2007.05.015.PubMedCrossRef

Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., et al. (2008). Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proceedings of the National Academy of Sciences of the United States of America, 105(48), 18782–18787. https://doi.org/10.1073/pnas.0810199105.PubMedPubMedCentralCrossRef

Wisor, J. P., Edgar, D. M., Yesavage, J., Ryan, H. S., McCormick, C. M., Lapustea, N., et al. (2005). Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer’s disease: a role for cholinergic transmission. Neuroscience, 131(2), 375–385. https://doi.org/10.1016/j.neuroscience.2004.11.018.PubMedCrossRef

Wood-Kaczmar, A., Gandhi, S., Yao, Z., Abramov, A. Y., Abramov, A. S. Y., Miljan, E. A., et al. (2008). PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons. PLoS ONE, 3(6), e2455. https://doi.org/10.1371/journal.pone.0002455.PubMedPubMedCentralCrossRef

Wu, Y.-H., Fischer, D. F., Kalsbeek, A., Garidou-Boof, M.-L., van der Vliet, J., van Heijningen, C., et al. (2006). Pineal clock gene oscillation is disturbed in Alzheimer’s disease, due to functional disconnection from the “master clock”. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 20(11), 1874–1876. https://doi.org/10.1096/fj.05-4446fje.CrossRef

Wu, D., & Pan, W. (2010). GSK3: A multifaceted kinase in Wnt signaling. Trends in Biochemical Sciences, 35(3), 161–168.PubMedCrossRef

Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., et al. (1999). Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell, 98(1), 115–124. https://doi.org/10.1016/S0092-8674(00)80611-X.PubMedCrossRef

Wu, Y.-H., & Swaab, D. F. (2005). The human pineal gland and melatonin in aging and Alzheimer’s disease. Journal of Pineal Research, 38(3), 145–152. https://doi.org/10.1111/j.1600-079X.2004.00196.x.PubMedCrossRef

Wulf, G., Finn, G., Suizu, F., & Lu, K. P. (2005). Phosphorylation-specific prolyl isomerization: is there an underlying theme? Nature Cell Biology, 7(5), 435–441. https://doi.org/10.1038/ncb0505-435.PubMedCrossRef

Wyse, C. A., & Coogan, A. N. (2010). Impact of aging on diurnal expression patterns of CLOCK and BMAL1 in the mouse brain. Brain Research, 1337, 21–31. https://doi.org/10.1016/j.brainres.2010.03.113.PubMedCrossRef

Xiong, H., Callaghan, D., Jones, A., Walker, D. G., Lue, L.-F., Beach, T. G., et al. (2008). Cholesterol retention in Alzheimer’s brain is responsible for high beta- and gamma-secretase activities and Abeta production. Neurobiology of Disease, 29(3), 422–437. https://doi.org/10.1016/j.nbd.2007.10.005.PubMedCrossRef

Xu, C., Wang, J., Zhu, T., Shen, Y., Tang, X., Fang, L., et al. (2016). Cross-talking between PPAR and WNT signaling and its regulation in mesenchymal stem cell differentiation. Current Stem Cell Research & Therapy, 11(3), 247–254.CrossRef

Yaffe, M. B., Schutkowski, M., Shen, M., Zhou, X. Z., Stukenberg, P. T., Rahfeld, J. U., et al. (1997). Sequence-specific and phosphorylation-dependent proline isomerization: A potential mitotic regulatory mechanism. Science (New York, N.Y.), 278(5345), 1957–1960.CrossRef

Yang, X., Downes, M., Yu, R. T., Bookout, A. L., He, W., Straume, M., et al. (2006). Nuclear receptor expression links the circadian clock to metabolism. Cell, 126(4), 801–810. https://doi.org/10.1016/j.cell.2006.06.050.PubMedCrossRef

Yang, G., Jia, Z., Aoyagi, T., McClain, D., Mortensen, R. M., & Yang, T. (2012a). Systemic PPARγ deletion impairs circadian rhythms of behavior and metabolism. PLoS ONE, 7(8), e38117. https://doi.org/10.1371/journal.pone.0038117.PubMedPubMedCentralCrossRef

Yang, S.-H., Li, W., Sumien, N., Forster, M., Simpkins, J. W., & Liu, R. (2015). Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots. Progress in Neurobiology. https://doi.org/10.1016/j.pneurobio.2015.10.005.CrossRefPubMedPubMedCentral

Yang, X., Wood, P. A., Ansell, C. M., Ohmori, M., Oh, E.-Y., Xiong, Y., et al. (2009). Beta-catenin induces beta-TrCP-mediated PER2 degradation altering circadian clock gene expression in intestinal mucosa of ApcMin/+ mice. Journal of Biochemistry, 145(3), 289–297. https://doi.org/10.1093/jb/mvn167.PubMedCrossRef

Yang, W., Xia, Y., Hawke, D., Li, X., Liang, J., Xing, D., et al. (2012b). PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell, 150(4), 685–696. https://doi.org/10.1016/j.cell.2012.07.018.PubMedPubMedCentralCrossRef

Yasuniwa, Y., Izumi, H., Wang, K.-Y., Shimajiri, S., Sasaguri, Y., Kawai, K., et al. (2010). Circadian disruption accelerates tumor growth and angio/stromagenesis through a Wnt signaling pathway. PLoS ONE, 5(12), e15330. https://doi.org/10.1371/journal.pone.0015330.PubMedPubMedCentralCrossRef

Yin, F., Boveris, A., & Cadenas, E. (2014). Mitochondrial energy metabolism and redox signaling in brain aging and neurodegeneration. Antioxidants & Redox Signaling, 20(2), 353–371. https://doi.org/10.1089/ars.2012.4774.CrossRef

Yuan, S., Shi, Y., & Tang, S.-J. (2012). Wnt signaling in the pathogenesis of multiple sclerosis-associated chronic pain. Journal of Neuroimmune Pharmacology: The Official Journal of the Society on NeuroImmune Pharmacology, 7(4), 904–913. https://doi.org/10.1007/s11481-012-9370-3.CrossRef

Yue, X., Lan, F., Yang, W., Yang, Y., Han, L., Zhang, A., et al. (2010). Interruption of β-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells. Brain Research, 1366, 27–37. https://doi.org/10.1016/j.brainres.2010.10.032.PubMedCrossRef

Yujnovsky, I., Hirayama, J., Doi, M., Borrelli, E., & Sassone-Corsi, P. (2006). Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK:BMAL1. Proceedings of the National Academy of Sciences of the United States of America, 103(16), 6386–6391. https://doi.org/10.1073/pnas.0510691103.PubMedPubMedCentralCrossRef

Zhang, S., Hulver, M. W., McMillan, R. P., Cline, M. A., & Gilbert, E. R. (2014). The pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility. Nutrition & Metabolism, 11(1), 10. https://doi.org/10.1186/1743-7075-11-10.CrossRef

Zhang, Z.-X., Li, Y.-B., & Zhao, R.-P. (2017). Epigallocatechin gallate attenuates β-amyloid generation and oxidative stress involvement of PPARγ in N2a/APP695 cells. Neurochemical Research, 42(2), 468–480. https://doi.org/10.1007/s11064-016-2093-8.PubMedCrossRef

Zhang, H.-M., & Zhang, Y. (2014). Melatonin: A well-documented antioxidant with conditional pro-oxidant actions. Journal of Pineal Research, 57(2), 131–146. https://doi.org/10.1111/jpi.12162.PubMedCrossRef

Zhang, K., Zhang, J., Han, L., Pu, P., & Kang, C. (2012). Wnt/beta-catenin signaling in glioma. Journal of Neuroimmune Pharmacology: The Official Journal of the Society on NeuroImmune Pharmacology, 7(4), 740–749. https://doi.org/10.1007/s11481-012-9359-y.CrossRef

Zhao, X., Strong, R., Zhang, J., Sun, G., Tsien, J. Z., Cui, Z., et al. (2009). Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 29(19), 6186–6195. https://doi.org/10.1523/JNEUROSCI.5857-08.2009.CrossRef

Zhou, W., Cai, F., Li, Y., Yang, G. S., O’Connor, K. D., Holt, R. A., et al. (2010). BACE1 gene promoter single-nucleotide polymorphisms in Alzheimer’s disease. Journal of Molecular Neuroscience: MN, 42(1), 127–133. https://doi.org/10.1007/s12031-010-9381-6.PubMedCrossRef

Zhou, T., Zu, G., Zhang, X., Wang, X., Li, S., Gong, X., et al. (2016). Neuroprotective effects of ginsenoside Rg1 through the Wnt/β-catenin signaling pathway in both in vivo and in vitro models of Parkinson’s disease. Neuropharmacology, 101, 480–489. https://doi.org/10.1016/j.neuropharm.2015.10.024.PubMedCrossRef

Zuo, L., Hemmelgarn, B. T., Chuang, C.-C., & Best, T. M. (2015). The role of oxidative stress-induced epigenetic Alterations in amyloid-β production in Alzheimer’s disease. Oxidative Medicine and Cellular Longevity, 2015, 604658. https://doi.org/10.1155/2015/604658.PubMedPubMedCentralCrossRef

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway–PPAR Gamma, Energy Metabolism and Circadian Rhythms

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2018

Improved Bioavailability of Levodopa Using Floatable Spray-Coated Microcapsules for the Management of Parkinson’s Disease

How to Spot Congenital Myasthenic Syndromes Resembling the Lambert–Eaton Myasthenic Syndrome? A Brief Review of Clinical, Electrophysiological, and Genetics Features

GWAS-Supported CRP Gene Polymorphisms and Functional Outcome of Large Artery Atherosclerotic Stroke in Han Chinese

Secretome of Differentiated PC12 Cells Restores the Monocrotophos-Induced Damages in Human Mesenchymal Stem Cells and SHSY-5Y Cells: Role of Autophagy and Mitochondrial Dynamics

BDNF/TrkB Pathway Mediates the Antidepressant-Like Role of H2S in CUMS-Exposed Rats by Inhibition of Hippocampal ER Stress